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Abstract  
 Background: Arabic is the mother tongue of 26 countries, including Saudi Arabia where 
cancer is the fourth leading cause of death. Cancer is a sensitive issue in the Arabic 
population and a clear understanding of patients’ perceptions of self-efficacy for coping 
with cancer and quality of life helps assess interventions designed to facilitate optimal 
patient outcomes.  In preliminary studies, the Cancer Behavior Inventory-Brief (CBI-B) 
was translated and back translated between English and Arabic, and reviewed for 
translational validity by an expert panel.  The Arabic version of the CBI-B (CBI-BA) had 
acceptable evidence of translational validity with an overall translational validity index of 
0.83. The CBI-BA was tested for evidence of internal consistency reliability with Arabic-
speaking patients with cancer in Houston, Texas. Cronbach’s alphas were ≥ .76, 
indicating acceptable evidence of reliability.   
Purpose: The purpose of this study was to develop psychometrically sound and 
culturally acceptable measures of self-efficacy for coping with cancer and quality of life 
for the Arabic-speaking population.   
Methods: Using a cross-sectional design, Arabic-speaking patients with cancer were 
recruited from two oncology centers in Riyadh, Saudi Arabia. All patients completed the 
CBI-BA; a randomly selected subsample participated in cognitive interviews to 
 vi 
determine semantic equivalence of the CBI-BA with the CBI-B. From the total sample, a 
subsample of women with breast cancer also completed the Arabic version of the 
Functional Assessment of Cancer Therapy –Breast (FACT-BA). Psychometric 
performance of both instruments was assessed for internal consistency reliability using 
Cronbach’s alpha (α) and construct validity using exploratory factor analyses, using 
principal axis factoring, with both orthogonal and oblique rotations.   
Results: Internal consistency estimates were acceptable for the CBI-BA (α = .79 -.80) 
and the total FACT-BA (α = .88) scales, but variable for the FACT-BA subscales (α = .63 
- .89).  Exploratory factor analyses showed evidence of construct validity for the CBI-
BA; one factor was derived, compared with four in the CBI-B. Cognitive interviews 
indicated satisfactory semantic equivalence of the CBI-BA with the CBI-B. The Breast 
Cancer subscale of the FACT-BA had inadequate α and a low response rate, which 
precluded testing construct validity. The Arabic version of the general FACT-G scale 
(FACT-GA) had four factors, according to expectation, in Arabic women with breast 
cancer. 
Conclusions and Implications: The CBI-BA has adequate evidence of translation 
validity, internal consistency reliability, construct validity, and semantic equivalence to 
measure self-efficacy for coping in Arabic-speaking patients with cancer. The FACT-GA, 
but not the FACT-BA, has adequate evidence of internal consistency and construct 
validity in Arabic-speaking women with breast cancer to measure quality of life. 
Demonstration of adequate psychometric performance of these instruments is expected to 
advance research with Arabic (1) patients with cancer by providing a means to assess 
self-efficacy for coping with cancer, and (2) women with breast cancer by providing a 
 vii 
means to assess the patient-centered outcomes of self-efficacy for coping with cancer and 
quality of life. 
 
Key words: Arabic, CBI-BA, cognitive interview, FACT-BA, quality of life, reliability, 
self-efficacy for coping, semantic equivalence, validity  
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Summary of the Study 
The dissertation involves three major parts: proposal, manuscript reporting the 
findings, and appendixes. The proposal was approved by the Dissertation Committee. 
The manuscript, “Psychometric performance of the Arabic versions of the Cancer 
Behavior Inventory-Brief and the Functional Assessment of Cancer Therapy-Breast in 
Saudi Arabia,” contains the dissertation findings. The appendixes contain two published 
articles (Appendixes A and B), results of the factor analyses that are not reported in the 
manuscript (Appendix C), translation certificates (Appendix D), and the author’s 
curriculum vitae (Appendix E). The articles in press were done as part of the PhD 
program coursework and the data served as preliminary support work for the dissertation. 
  The study used a cross-sectional design to test the psychometric performance of 
the Arabic versions of the Cancer Behavior Inventory-Brief (CBI-BA) and the Functional 
Assessment of Cancer Therapy-Breast (FACT-BA) among Arabic patients with cancer in 
Saudi Arabia. Randomly selected participants participated in cognitive interviews to 
determine the semantic equivalence of the CBI-BA with the CBI-B. The specific aims 
were to evaluate the evidence for (1) internal consistency reliability of the CBI-BA in the 
Arabic cancer population and in Arabic women with breast cancer using Cronbach’s 
alpha (α); (2) validity of the CBI-BA in the Arabic cancer population and in Arabic 
women with breast cancer using exploratory factor analysis (EFA) with principal axis 
factoring (PAF) and varimax and promax rotations; (3) internal consistency reliability of 
the FACT-BA among Arab women with breast cancer using α; and (4) validity of the 
FACT-BA among Arab women with breast cancer using EFA with PAF and varimax and 
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promax rotations. The aims were achieved with a total sample of 443 patients with 
cancer, of whom 168 were women with breast cancer.    
  Two preliminary studies were conducted that provided the foundation for the 
dissertation: Arabic translation of the CBI-B and pilot testing of the CBI-BA and the 
FACT-BA in Houston, Texas, USA. The findings from these studies are in Appendixes A 
and B.  
There were two deviations from the proposal approved by the Dissertation 
Committee. First, 443 participants were recruited instead of the planned 481, the latter 
based on an unknown, but projected, 30% attrition rate. The actual attrition rate was 
1.2%, and the obtained sample size exceeded the 370 participants needed to meet the 10:1 
subject-to-item ratio recommended for factor analysis. However, fewer women with 
breast cancer were recruited than expected (n= 168), so the subject-to-item ratio was 6:1 
for the FACT-BA factor analysis. Second, the 14-item CBI posted for public use was 
used for the preliminary studies and, thus was proposed for testing the related dissertation 
specific aims. This version did not perform according to expectation, and the 12-item 
version (Heizmann et al., 2011) also was subjected to factor analyses. The optimal 
solution is reported in the manuscript, “Psychometric performance of the Arabic versions 
of the Cancer Behavior Inventory-Brief and the Functional Assessment of Cancer 
Therapy-Breast;” the solutions for multiple exploratory factor analyses, with and without 
the Breast Cancer subscale, using orthogonal and oblique rotations are included in 
Appendix C to provide an audit trail.  
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Specific Aims  
Exploring self-efficacy for coping (SEC) with cancer and quality of life (QOL) in 
Arab populations would be beneficial for understanding attitudes toward cancer and its 
influence on coping abilities and QOL. Self-efficacy is conceptually defined as an 
individual’s belief in his/her abilities to perform a specific behavior under challenging 
conditions (Bandura, 1977), which can be measured in cancer populations using the 
Cancer Behavior Inventory-Brief (CBI-B) (Heitzmann et al., 2011). However, reliable 
and valid instruments for use with Arabic-speaking cancer patients are not available. 
Using World Health Organization (WHO, n.d) guidelines, the principal investigator (PI) 
translated the CBI-B from English to the Arabic language (CBI-BA) (Algamdi & 
Hanneman, 2014). In the proposed study, the PI will evaluate the psychometric 
performance of the translated version in Saudi Arabia.  
Culture has a complex influence on behaviors because it provides a source of 
information from which to develop SEC with cancer (Bandura, 2002; Oettingen, 1995), 
and culture heavily influences individuals’ abilities to cope with their illness. As such, 
not only language, but also cultural factors must be considered when measuring SEC. To 
validate semantic equivalence of the CBI-BA in the proposed study, cognitive 
interviewing will be done with Arabic-speaking patients who have been diagnosed with 
cancer. Semantic equivalence would indicate that the CBI-BA reflects the exact meaning 
of the original CBI-B in the context of the Arabic culture. The PI’s long-term goal is to 
use the CBI-BA with Saudi women with breast cancer, but patients diagnosed with all 
types of cancer will be recruited in the proposed study to test the instrument’s 
psychometric performance in the larger cancer population.  
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Heitzmann et al. (2011) stated that exploring SEC is important because it has a 
significant influence on overall QOL of the cancer population. In addition, QOL is a 
major indicator of health condition among cancer patients (Lee et al., 2013). WHO 
(1997) defined QOL as “individuals’ perception of their position in life in the context of 
the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns” (p. 1). Determinants of QOL include physical 
functioning, general health, pain, fatigue, and well-being (Theadom, Cropley, & 
Humphrey, 2007). Self-efficacy has a positive effect on enhancing QOL over time, 
especially for those undergoing cancer treatment (Cheng et al., 2012). Therefore, 
measuring QOL of Arabic women with breast cancer is important for determining how 
their condition influences their lives. QOL of women with breast cancer can be measured 
using the Functional Assessment of Cancer Therapy-Breast (FACT-B) (Brady et al., 
1997). An Arabic version of the FACT-B is available, but evidence of reliability and 
validity of the Arabic version of the FACT-B (FACT-BA) has not been reported. Hence, 
the psychometric properties of this instrument also need to be estimated.  
The investigator’s future plans include testing interventions to improve SEC and 
QOL of women with breast cancer in Saudi Arabia. If the CBI-BA and FACT-BA 
demonstrate acceptable psychometric performance, the instruments will be used in future 
research. The findings from the proposed psychometric testing will inform practice and 
research of the measurement of SEC in the Arabic-speaking cancer population and QOL 
of Arabic-speaking women with breast cancer. The purpose of the proposed study is to 
evaluate the psychometric performance of the CBI-BA and the FACT-BA in the Arabic-
speaking cancer population. It is hypothesized that the (1) evidence of reliability for the 
CBI-BA AND FACT-BA PSYCHOMETRICS                                                             6                              
 
 
CBI-BA and the FACT-BA will be acceptable (Cronbach’s alpha ≥ 0.70), and (2) 
evidence of validity will be demonstrated by the loading of instrument items on factors 
representing instrument subscales according to theoretical expectations.  The specific 
aims are to: 
Specific aim 1: Evaluate evidence for reliability of the CBI-BA in the Arab cancer 
population, then in Arab women with breast cancer, by testing evidence of internal 
consistency using Cronbach’s alpha (α); 
Specific aim 2: Evaluate evidence for validity of the CBI-BA in the Arab cancer 
population, then in Arab women with breast cancer, by exploratory factor analysis (EFA) 
using principal axis factoring (PAF) with varimax rotation; 
Specific aim 3: Evaluate evidence for reliability of the FACT-BA among Arab women 
with breast cancer by testing evidence of internal consistency using α; and 
Specific aim 4: Evaluate evidence for validity of the FACT-BA among Arab women 
with breast cancer by EFA using PAF with varimax rotation.   
The findings of this study will help inform research and practice with the Arab cancer 
population, with a particular focus on women with breast cancer.  
Research strategies: 
(a) Signifiance  
Salim et al. (2009) reported that about 300 million people are citizens of the Arab 
world. According to One World Nation Online (n.d.), Arabic is the official language of 
26 countries distributed across Asia and Africa. In the Middle East, cancer is the fourth 
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leading cause of death (WHO, 2009). In 1998–2001, cancer cases in Gulf Cooperation 
Council countries totaled 32,291 (Al-Hamdan et al., 2009), indicating that a reasonable 
number of Arabic-speaking people may benefit from the availability of valid and reliable 
instruments to measure SEC and QOL. Moreover, SEC has a substantial impact on 
overall QOL in cancer populations (Heitzmann et al., 2011), and psychometrically sound 
measures of SEC and QOL for use with the Arabic-speaking population is expected to 
facilitate improved care of those with cancer. Cancer has a major impact on QOL, which 
is an essential factor for describing the health status of cancer populations (Lee et al., 
2013).  
In brief, cancer influences physical and psychological aspects of people’s lives 
(Stein, Syrjala, & Andrykowski, 2008), not only at the time of diagnosis and treatment 
but long afterwards as well (Drake, 2012). SEC with cancer appears to predict QOL and 
increase survival (Yeung, Lu, & Lin, 2014). Therefore, measuring SEC in Arab 
individuals with cancer could indicate issues they face during their illness and the course 
of treatment that reflect on their overall QOL. Using a reliable and valid instrument to 
measure the concept of SEC with respect to language and cultural differences is crucial. 
On that basis, the intent is to maintain equivalence between English and Arabic measures 
of SEC. A literal translation of the CBI-B is insufficient; the participant’s understanding 
of instrument items is essential to the validity of the concept(s) being measured with the 
instrument. Hence, cognitive interviewing will be used as a qualitative determination 
(Reeve et al., 2011) of participant understanding of each CBI-BA item, and items that are 
not understood as intended will be reworded.  
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Culture is a key component of QOL because it explains how people function 
within their environment (Skevington, 2002). Cancer is considered a stigma among Arab 
people, and in Arab women, in particular, fear, shyness, and stigma affect attitudes 
toward breast cancer and coping (Alam, 2006; Amin, Almulhim, & Almeqihwi, 2009; 
Sarhan, 2009). Coping issues can affect overall QOL including physical, emotional, 
social, and functional well-being. The characteristics of Arab women with breast cancer 
differ from those of American and European women; Arab women are often diagnosed at 
a younger age (AbdelHadi, 2006) with a more advanced stage of cancer (Chouchane, 
Boussen, & Sastry, 2013). Women with breast cancer experience good or poor QOL 
based on the level of their SEC; good QOL reflects a high level of SEC, while poor QOL 
indicates a low level of SEC (Akin, Can, Durna, & Aydiner, 2008; Heitzmann et al., 
2011). Arab women, in particular, experience anxiety and shame that affect their attitudes 
toward breast cancer (Alam, 2006; Amin, Almulhim, & Almeqihwi, 2009; Sarhan, 2009). 
Such psychological attributes are theorized as adverse influences on QOL and SEC in 
Arab women with breast cancer. Moreover, cross-cultural measures are essential for use 
in international studies (Skevington, 2002), and research with Arab populations would 
benefit from psychometrically sound instruments in the Arabic language.  
The purpose of this study is to test the psychometric performance of the CBI-BA 
and the FACT-BA in an Arabic-speaking sample of people with cancer and women who 
have been diagnosed with breast cancer. In addition, cognitive interviews with the 
participants will determine the semantic equivalence of the CBI-BA with the CBI-B. 
Because there are no known valid and reliable measures for SEC for Arab people with 
cancer and QOL for Arab women with breast cancer, the proposed study will serve as the 
CBI-BA AND FACT-BA PSYCHOMETRICS                                                             9                              
 
 
building block for future research using quantitative and qualitative methods to develop 
and/or test instruments for use in Arab populations. 
Conceptual Framework. Figure 1 illustrates the relation between SEC and QOL 
in people with cancer.  Individual characteristics determine responses to cancer diagnosis; 
these characteristics include knowledge, attitude, culture, and social influences. 
Responses to cancer diagnosis and treatment influence coping abilities (Lev, 1997). High 
SEC leads to positive behaviors reflected in high QOL (Heitzmann et al., 2011). On the 
other hand, low level of SEC influences coping behaviors in a negative manner, leading 
to poor QOL (Akin, Can, Durna & Aydiner, 2008; Yeung, Lu & Lin, 2014). In the 
proposed study the PI will measure SEC in Arab people with cancer and QOL in Arab 
women with breast cancer using the CBI-BA and the FACT-BA, respectively. These 
measurements are expected to show the nature of the correlation between SEC and QOL, 
which will be helpful in developing a psychosocial program to improve both SEC and 
QOL in Arab women with breast cancer.  
(b) Innovation 
The PI translated the CBI-B into the Arabic language using the WHO process for 
translating instruments (WHO, n.d). The process included forward translation, back 
translation, use of an expert panel, pretesting, and cognitive interviewing. A 
psychometrically sound instrument to measure SEC in Arab cancer populations, and 
especially for women with breast cancer, will facilitate cancer research. Psychometric 
performance has not been reported for the FACT-B Arabic version.         
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Figure1. Conceptual framework shows the relation between self-efficacy for coping and 
quality of life (QOL) in patients with cancer. 
(c) Approach 
Psychometric testing of the CBI-BA and the FACT-BA will be done with 
Cronbach’s alpha for internal consistency reliability and EFA with PAF for construct 
validity. Furthermore, the semantic equivalence of the CBI-BA will be determined using 
cognitive interviewing (Reeve et al., 2011) to ascertain participant understanding of each 
translated item.  
Preliminary Studies  
Study # 1- Fifty cancer patients who speak Arabic were recruited to test evidence 
for reliability of the CBI-BA. Forty-seven of them (94%) completed the questionnaire. 
Cronbach’s alpha was .77, suggesting adequate internal consistency evidence (DeVellis, 
2012). Of 17 women with breast cancer, 16 of them (94%) completed the CBI-BA and 
Cronbach’s alpha was .78, indicating an acceptable level of internal consistency. 
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Cognitive interviewing revealed that 5 of 6 participants recommended rewording the 
word “independence” in the first item to “self-reliance.” Additionally, most of the 
participants found use of the word “cancer” to be bothersome. Therefore, the word 
“cancer” was changed to “disease.” Of the 17 women with breast cancer, 12 (71%) 
completed the the FACT-BA.  Cronbach’s alpha was .67, indicating inadequate evidence 
for reliability. Two items of the FACT-BA had minimal response rates: item 7 in the 
Social Wellbeing scale and item 4 in the Additional Concerns scale (i.e., Breast Cancer 
subscale); both are related to sexual issues. After excluding these items, the alpha 
increased to .91, indicating adequate evidence of internal consistency. Both instruments 
were revised accordingly. The word “independence” was changed to “self-reliance” in 
item 1 of the CBI-BA, and the word “cancer” was replaced throughout the instrument 
with the word “disease.” Item 4 of the FACT-BA Additional Concerns subscale was 
made optional; item 7 in the Social Wellbeing subscale already is optional. Psychometric 
testing was resumed with these changes in the instruments. 
Study # 2 - Evidence for reliability of the revised versions of the CBI-BA and the 
FACT-BA was tested with another sample of 50 cancer patients, including 13 women 
with breast cancer. For the revised CBI-BA, 47 patients (94%) completed the instrument; 
Cronbach’s alpha was .77, suggesting acceptable internal consistency. Thirteen women 
with breast cancer responded to the revised CBI-BA. The Cronbach’s alpha was .67, 
indicating inadequate evidence of internal consistency. Revisions to the CBI-BA did not 
improve the internal consistency, but did facilitate cognitive understanding of the items 
by participants. Cognitive interviews indicated that items 5, 10, and 13 required revision. 
“Putting things out of my mind at times” will be changed to “Talk about things in my 
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mind at times;” “Seeking social support” will be changed to “Seek support from others 
such as family, friends, groups, and organizations” with use of a different synonym for 
the word “support” in Arabic; and “Coping with physical challenges” will be changed to 
“Coping with physical difficulties.”  
  Reliability of the FACT-BA was tested on 13 women with breast cancer. 
Cronbach’s alpha was .87 for the total scale and .91 after deleting item 7 in the Social 
Wellbeing scale and item 4 in the Additional Concerns scale. Internal consistency of the 
instrument was improved after the revisions.    
  The overall attrition rates were as follows: CBI-BA, 8% and FACT-BA, 7%. 
Reasons for attrition were missing answers for one or two items on the questionnaire.                      
Design 
Using a cross-sectional design, participants will complete the CBI-BA once and 
those diagnosed with breast cancer will be asked to also complete the FACT-BA. From 
the participant list, 30 participants will be selected randomly to be cognitively 
interviewed about the CBI-BA. The random selection will be done using random 
assignment software available at http://www.randomizer.org/form.htm.   
Sample and Setting 
The planned sample size is 370 participants for the CBI-BA (14 items) and the 
FACT-BA (35 - 37 items) to provide at least 10 subjects per item for factor analysis 
(DeVellis, 2012; Froman, 2001). Although the overall attrition rate was approximately 
8% in the preliminary studies, it is unknown what the attrition rate will be in Saudi 
Arabia. Allowing for an attrition rate as high as 30%, 481 women will be recruited. A 
convenience sample of Arabic-speaking adults will be recruited from three oncology 
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centers located in three hospitals in Riyadh, Saudi Arabia: King Fahad Medical City, 
National Guard Ministry of Health Affairs, and Prince Sultan Military Medical City. To 
facilitate recruitment, oncologists will be requested to notify patients of the study at the 
patient’s regular appointment time, and flyers (Appendix A) will be posted in waiting 
rooms of the oncology centers. The snowball sampling technique (Polit & Beck, 2012) 
will be used, whereby participants are asked to tell people they know who have cancer 
about the study. 
Study inclusion criteria are age between 18 and 75 years, diagnosed with cancer, 
and able to read and write Arabic. The exclusion criterion is participant sensory and/or 
cognitive deficits as determined by inability to communicate verbally and understand 
verbal instructions.   
Instruments 
The CBI-B (Appendix B) is a 14-item, self-report, norm-referenced, paper-and-
pencil instrument developed to measure SEC of cancer patients (Heitzmann et al., 2011); 
it takes ≤ 5 minutes to complete. Heitzmann and colleagues reported evidence of 
adequate internal consistency (Cronbach’s alphas .84 - .88). They also demonstrated 
evidence of construct validity with factor analysis (N=735); the hypothesized four 
subscales were supported by the loading of all items on a four-factor solution. The 
subscales of the CBI-B are maintaining independence and positive attitude, participation 
in medical care, coping and stress management, and managing affect. The CBI-B uses a 
9-point, Likert-type scale (1 = not at all confident, 9 = totally confident).  The sum of the 
item scores indicates the level of SEC, with higher scores reflecting a stronger self-
efficacy for coping than lower ones (Heitzmann et al., 2011). Based on participant 
CBI-BA AND FACT-BA PSYCHOMETRICS                                                             14                            
 
 
feedback from cognitive interviewing, as reported in the Preliminary Studies, the revised 
CBI-BA (also in Appendix B) will be used. Demographic data of age, gender, and type of 
cancer diagnosis is collected on the CBI-BA for description of the sample.    
The FACT-B (Appendix C) is a 37-item, self-report, norm-referenced, paper-and-
pencil instrument developed to measure QOL of women with breast cancer (Brady et al., 
1997); it takes about 10 minutes to complete.  Brady and colleagues reported adequate 
internal consistency (Cronbach’s alpha = .90) and construct validity evidence.  Factor 
analysis (N=295) supported the hypothesized five subscales. The subscales are physical, 
social/family, emotional, and functional well-being, and additional concerns (breast 
cancer subscale). The FACT-B uses a 5-point Likert-type scale, scored from 0 (not at all) 
to 4 (very much). An Arabic version of the FACT-B is available for use. The FACT-BA 
(also in Appendix C) was revised for the proposed study as discussed under Preliminary 
Studies. 
Data Collection Procedures 
The data collection steps are summarized below and detailed in Appendix D. Prior 
to study initiation, the code number assigned to 30 participants will be randomly selected 
by computer to select the participants to approach for cognitive interviews. When 10 
selected participants have declined participation in the cognitive interviews, replacement 
code numbers will be selected by computer randomization. Participants assigned the 
interview study identification codes will be asked to participate in a brief cognitive 
interview after completion of the CBI-BA. The data collection form for the cognitive 
interview is in Appendix E.  
CBI-BA AND FACT-BA PSYCHOMETRICS                                                             15                            
 
 
After introductions, the volunteer will be given the informed consent (Appendix 
F) document to read and the PI will review the content with the volunteer in Arabic, 
emphasizing that the information the participant provides will be confidential and used 
for research purposes only. After consent to study participation has been provided, the 
participant will be given the CBI-BA to complete. Women with breast cancer will be 
asked also to complete the FACT-BA. Participants selected for cognitive interviewing 
will be asked the following questions about each item on the CBI-BA: (a) What did this 
question mean to you? (b) Why did you select this answer? and (c) Can I rephrase this 
question to make it easier to understand? If so, how? Participants’ responses will be 
recorded manually and discussed with the co-investigator and a professional translator. 
The feedback will be used for possible future modification of items that were confusing 
to participants.     
Data Management and Analysis  
All data will be de-identified, including paper questionnaires and interview notes, 
remain in possession of the investigators, and stored in a double-locked room in the 
advisor’s office at the University of Texas Health Science Center at Houston School of 
Nursing. 
Responses to the instruments will be entered into an Excel database and imported 
into SPSS statistical software (IBM Corp. Armonk, NY). Items on the FACT-BA will be 
reverse-scored as outlined in Appendix D.  Responses from 5 participants will be selected 
randomly from every consecutive set of 50 participants to verify accuracy of data entry 
(i.e., 10% of completed questionnaires). If the data entry error rate exceeds 5%, all data 
will be double-checked for accuracy (EMGO Institute of Health and Care Research, 
2013). Data analysis will include descriptive statistics, Cronbach’s alpha for internal 
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consistency, and EFA with PAF for construct validity. Measures of central tendency and 
dispersion appropriate for the level of data will be computed for the sample 
demographics and item and total scores for the CBI-BA and the FACT-BA. The 
distribution of data will be assessed with histogram and the Kolmogorov-Smirnov 
normality test.  
Cronbach’s alpha for the CBI-BA will be computed for all participants with 
cancer, and separately for women with breast cancer (Aim 1). Cronbach’s alpha for the 
FACT-BA will be computed for women with breast cancer (Aim 3).  Cronbach’s α ≥ .70 
will be considered evidence of adequate internal consistency (Nunnally & Bernstein, 
1994). 
   Separate EFAs using PAF with varimax rotation will be conducted for the CBI-
BA for all participants with cancer and for women with breast cancer (Aim 2). EFA with 
PAF and varimax rotation for the FACT-BA will be conducted for women with breast 
cancer (Aim 4). The scree plot will be used to determine the number of factors extracted.  
A priori criteria for an acceptable solution include factor loadings ≥ .30, cross-loadings > 
.20, and ≥ 3 items per factor (Leech, Barrett & Morgan, 2011; DeVellis, 2012). Based on 
the hypothesized subscales, the results should be a four-factor solution for the CBI-BA 
and a five-factor solution for the FACT-BA.  
  The participants’ comments from cognitive interviewing will be collated by item 
and described. Instrument items with more than nine constructive comments will be 
recommended for future revision.  The PI selected nine as the criterion for revision based 
on the anticipated total of 30 participants interviewed; nine or more comments would 
indicate that approximately 30% of participants had difficulty with the item. Fewer than 
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nine constructive comments, together with acceptable explanation of the response choice, 
will indicate acceptable semantic equivalence (Beck, Bernal, & Froman, 2003) of the 
CBI-BA with the CBI-B.  
Study Timeline 
The proposed study is anticipated to take place between February and July 2015 
as shown below.  
 November 2014 
December 
2014 
January 
2015 
February 
2015 
March 
2015 
April 
2015 
May 
2015 
June   
2015
July 
2015
Approvals     
Data 
collection  
   
Data 
analyses 
   
Writing 
dissertation 
   
Revisions     
Defenses      
 
Study Limitations 
Women in the Arabian culture are reluctant to reveal personal information 
(Sarhan, 2009), and female study participants may be hesitant to share their thoughts 
about cancer. Participants will be assured that confidentiality will be maintained. No 
personal identifiers will be collected from the participants. The interviewer will be an 
Arabian female which should decrease anxiety and discomfort of the female participants. 
Protection of Human Subjects 
Institutional review board approvals of the study from the University and two 
Saudi hospitals are in Appendix G. The consent dialog will be done on a one-to-one basis 
in waiting rooms of selected oncology clinics. The participant will have adequate time to 
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discuss the study with the investigator and review the consent form. The investigator will 
give a copy of the consent form to the participant and offer additional time for the 
participant to consider participation in the study. Verbal consent will be obtained from 
study participants to ensure they understand the purpose of the study and uses of the 
information they provide. Participants will be free to withdraw at any time and refuse to 
answer any items on the instrument(s). Verbal consent will be used to avoid loss of 
confidentiality, the only potential risk to participants. The study consent form will be 
attached to the instrument(s) as a cover letter to inform the participant of the purpose of 
the study and explain the role and rights as a participant. By reading the consent and 
completing the instrument(s), and interview if appropriate, the participant will be giving 
consent for study participation. 
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Appendix A 
Recruitment Flyer 
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Adult Volunteers Needed to Test 
Arabic Version of Cancer 
Questionnaire(s) 
If your age is 18-75 years 
and 
you have been diagnosed with cancer, 
you are invited to participate in a study to test validity 
and reliability of one or two questionnaires. 
Your participation in the study is appreciated because it 
could help with research and care of Arabic speaking 
patients with cancer. 
Time commitment: 5 minutes for the CBI-BA and 10 
minutes for the FACT-BA (women with breast cancer only) 
If you are willing to take a part in the study, please do 
not hesitate to contact Maaidah Algamdi at 
Phone number: 0560091866 
Email: Maaidah.Algamdi@uth.tmc.edu 
 
 
                            72                                                             SCIRTEMOHCYSP AB-TCAF DNA AB-IBC
 
 
من  مطلوب متطوعين بالغين لاختبار النسخه العربيه
 استبيانات تخص مرضى السرطان
  وقد تم تشخيصك بالسرطان 57 -81اذا كان عمرك من 
يان او انت مدعو للمشاركه في دراسه للتحقق من صدق وثبات استب
 اثنان
ث في مجال البحمشاركتكم ھي محل تقديرنا حيث انھا قد تساعد 
 والرعاية الصحية لمرضى السرطان الناطقين باللغه العربيه
ياس الكفاءه الوقت المطلوب لتعبئة الاستبيانات:عشردقائق لاستبان ق
 الذاتيه لمواجة السرطان خمس عشرة دقيقه لقياس نمط الحياة
ردد اذا كنت اوكنتي على استعداد للمشاركه في ھذه الدراسه لا تت
  في الاتصال علىاوتترددين 
 معيضه الغامدي
 جوال:
 6681900650
 ايميل:
 ude.cmt.htu@idmaglA.hadiaaM
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Appendix B 
The Cancer Behavioral Inventory-Brief and Arabic version of Cancer 
Behavioral Inventory-Brief 
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The Cancer Behavioral Inventory-Brief Arabic in English  
Please complete the following: 
1- Demographics: 
                            Age: ___________   Gender: ___________   Type of Cancer: ____________  
2- Questionnaire about cancer patient behavior:  
This questionnaire consists of things a person might do when receiving cancer treatment. We are interested 
in your level of confidence for performance of these things. Be sure that these ratings precisely reflect your 
confidence whether you did it before or not. Therefore, the rating will reflect your level of confidence in 
the performance of these things in the present (or in the near future).  Please read each numbered item, then 
rate your level of confidence in the performance of this behavior. Put a circle around the number in the 
rating scale. If you circle number “1”, you mean that you are not at all confident in performing this 
behavior. If you circle number “9”, you mean that you are totally confidant in performing this behavior. 
The numbers in the middle of the scale show that you are somewhat confidant in performing this behavior.  
Please rate all items. If you are not sure about certain items, please provide the best rating you can. 
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant
1- Maintain self-reliance               1              2              3              4              5              6              7               8             9  
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
2- Maintain positive attitude         1              2              3              4              5              6              7               8             9 
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
3- Maintain sense of humor          1              2              3              4              5              6              7               8             9       
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
4- Expressing feelings                   1              2              3              4              5              6              7               8             9      
about the disease                                
                                        Not Confidant at all                 Somewhat Confidant                    Totally Confidant  
5- Talk about things on my           1              2              3              4              5              6              7               8             9      
mind at times  
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant  
6- Maintain activities (work,        1              2              3              4              5              6              7               8             9        
home, hobbies, social)                                  
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
7- Try to be calm during               1              2              3              4              5              6              7               8             9       
treatment and avoid frightening ideas  
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
8- Participate actively in               1              2              3              4              5              6              7               8             9      
treatment decisions                                 
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
9- Ask physician questions           1              2              3              4              5              6              7               8             9       
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
10- Seek support from                      1              2              3              4              5              6              7               8             9  
others such as family, friends, groups, and organizations                     
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
11- Share my fears and                    1              2              3              4              5              6              7               8             9      
concerns with others                             
                                         Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
12.   Control nausea and                 1              2              3              4              5              6              7               8             9         
vomiting (whether you have had it before or not)                                                                                                          
                                      Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
13.   Cope with physical                1              2              3              4              5              6              7               8             9          
difficulties                                        
                                        Not Confidant at all                 Somewhat Confidant                    Totally Confidant 
14.   Try to maintain calm during  1              2              3              4              5              6              7               8             9 
waiting for appointment for one hour or more                                   
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 الرجاء كتابة مايلي:
  معلومات عامه  - 1
  ----------------------------- نوع السرطان                       ---------- الجنس                    -------- العمر                                  
  استبيان سلوك مريض السرطان   - 2
 يحتوي ھذا الاستبيان على امور قد يقوم بھا الشحص عندما يتلقى علاج السرطان 
ء قمت ام لم تقم واون بتقييمك لمدى ثقتك في امكانية انجازك لھذه الامور.تأكد من ان التقييمات تعكس بدقه مدى ثقتك سنحن مھتم
 بھا في السابق
  ريبوبالتالي فان ھذه التقييمات تعكس مدى ثقتك في امكانية انجازك لھذه الامور حاليا )او في المستقبل الق
موجود في م ھذا العنصر حول مدى ثقتك في امكانية انجاز ھذا السلوك. ضع دائره على الرقم الالرجاء قراءة كل عنصر مرقم, ثم قي
فانك توضح انك غير واثق تماما من انه يمكنك انجاز ھذا التصرف. اذا وضعت دائره  1اذا وضعت دائره على رقم مقياس التقييم
شير الى انك التصرف . اما الارقام التي فو وسط مقياس التقييم فتفانك توضح انك واثق تماما من انه يمكنك انجاز ھذا  9على رقم 
عطاء افضل الرجاء تقييم كافة العناصر . اذا لم تكن متأكدا بشأن عنصر ما فالرجاء ا واثق نوعا ما في امكانية قيامك بھذا السوك
 تقييم ممكن                     
  غير واثق تماما واثق نوعا ما واثق تماما
  المحافظة على الاعتماد على النفس .1  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 المحافظه على الموقف الايجابي .2  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 المحافظة على روح الدعابة .3  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 التعبيرعن المشاعرالخاصة بالمرض .4  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 أحياناالتحدث عن ما يدوربفكري  .5  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 المحافظةعلى الانشطة )العمل,المنزل, الھوايات,الأمور الاجتماعية( .6  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 محاولة الھدوء اثناء العلاج وعدم السماح للافكار المخيفة ان تقلقني .7  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 قرارات العلاجالمشاركة بفاعلية في  .8  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 طرح اسئلة على الطبيب .9  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 المنظماتو,المجموعات العائله, الاصدقاء,ه من ندالسعي لطلب المسا .01  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
 مشاركة مخاوفي وما يقلقني مع الاخرين .11  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
  3      2          1  6       5       4  9     8       7
التحكم في القيء والغثيان سواء كنت اعاني من ھذه المشاكل من قبل  .21
 ام لا
   غير واثق تماما واثق نوعا ما واثق تماما
 مواجھة الصعوبات البدنية .31  3      2          1  6       5       4  9     8       7
   غير واثق تماما واثق نوعا ما واثق تماما
  3      2          1  6       5       4  9     8       7
محاولة الھدوء اثناء الانتظار لمدة ساعة واحدة على الاقل في موعد  .41
 العلاج الخاص بي
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Appendix C 
The Functional Assessment of Cancer Therapy-Breast and the Arabic version of 
Functional Assessment of Cancer Therapy-Breast  
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Below is a list of statements that other people with your illness have said are important. Please 
circle one number per line to indicate your response as it applies to the past 7 days. 
 
 
 PHYSICAL WELL-BEING 
 
Not 
at 
all 
A 
little 
bit 
Some
-what 
Quite 
a bit 
Very 
much 
GP1 I have a lack of energy  0 
 
1 
 
2 
 
3 
 
4 
GP2 I have nausea  0 
 
1 
 
2 
 
3 
 
4 
GP3 
Because of my physical condition, I have 
trouble meeting the needs of my 
Family 
 
0 
 
1 
 
2 
 
3 
 
4 
GP4 I have pain  0 
 
1 
 
2 
 
3 
 
4 
GP5 I am bothered by side effects of treatment  0 
 
1 
 
2 
 
3 
 
4 
GP6 I feel ill  0 
 
1 
 
2 
 
3 
 
4 
GP7 I am forced to spend time in bed  0 
 
1 
 
2 
 
3 
 
4 
 SOCIAL/FAMILY WELL-BEING 
 
Not 
at 
all
A 
little 
bit
Some
-what 
Quite 
a bit 
Very 
much 
GS1 I feel close to my friends  0 
 
1 
 
2 
 
3 
 
4 
GS2 I get emotional support from my family  0 
 
1 
 
2 
 
3 
 
4 
GS3 I get support from my friends  0 
 
1 
 
2 
 
3 
 
4 
GS4 My family has accepted my illness  0 
 
1 
 
2 
 
3 
 
4 
GS5 I am satisfied with family communication about  my illness 
 
0 
 
1 
 
2 
 
3 
 
4 
GS6 I feel close to my partner (or the person who is my main support) 
 
0 
 
1 
 
2 
 
3 
 
4 
Q1 
Regardless of your current level of 
sexual activity, please answer the 
following question. If you prefer not to 
answer it, please mark this box            
and go to the next section. 
     
GS7 I am satisfied with my sex life  0 
 
1 
 
2 
 
3 
 
4 
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.past 7 daysapplies to the  one number per line to indicate your response as it Please circle 
 EMOTIONAL WELL-BEING Not 
at 
all 
A 
little 
bit 
Some-
what 
Quit
e a 
bit 
Very 
much 
GE1 I feel sad ........................................................ 0 1 2 3 4 
GE2 I am satisfied with how I am coping with 
my illness ...................................................... 0 1 2 3 4 
GE3 I am losing hope in the fight against my 
illness ............................................................ 0 1 2 3 4 
GE4 I feel nervous ................................................ 0 1 2 3 4 
GE5 I worry about dying ...................................... 0 1 2 3 4 
GE6 I worry that my condition will get worse ...... 0 1 2 3 4 
 
 FUNCTIONAL WELL-BEING Not 
at all 
A 
little 
bit 
Some-
what 
Quite 
a bit 
 Very 
much 
GF1 I am able to work (include work at home) ....... 0 1 2 3 4 
GF2 My work (include work at home) is 
fulfilling ...........................................................
0 1 2 3 4 
GF3 I am able to enjoy life ...................................... 0 1 2 3 4 
GF4 I have accepted my illness ............................... 0 1 2 3 4 
GF5 I am sleeping well ............................................ 0 1 2 3 4 
GF6 I am enjoying the things I usually do for fun ... 0 1 2 3 4 
GF7 I am content with the quality of my life 
right now .......................................................... 0 1 2 3 4 
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Please circle one number per line to indicate your response as it applies to the past 7 days  
 ADDITIONAL CONCERNS 
 
Not 
at 
all 
A 
littl
e 
bit 
Som
e-
what 
Quit
e a 
bit 
Very 
much 
 
B1 I have been short of breath .............................. 0 1 2 3 4 
B2 I am self-conscious about the way I dress ....... 0 1 2 3 4 
B3 One or both of my arms are swollen or 
tender ...............................................................
0 1 2 3 4 
Q2 
 
 
B4 
If you prefer not to answer, please mark 
this box       and go to the next item. 
 I feel sexually attractive .................................
 
0 
 
1 
 
2 
 
3 
 
4 
B5 I am bothered by hair loss ............................... 0 1 2 3 4 
B6 I worry that other members of my family 
might someday get the same illness I have .....
 
0 
 
1 
 
2 
 
3 
 
4 
B7 I worry about the effect of stress on my 
illness ...............................................................
0 1 2 3 4 
B8 I am bothered by a change in weight ............... 0 1 2 3 4 
B9 I am able to feel like a woman ........................ 0 1 2 3 4 
P2 I have certain parts of my body where I 
experience pain ................................................ 0 1 2 3 4 
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من فضلك ضع دائرة أو علامة على رقم  ذكر أشخاص بنفس علتك أنھا مھمة بالنسبة لھم.ھذه قائمة بالعبارات التي 
  .الأيام السبعة الأخيرةفي  حالتككل سطر لبيان مدى انطباق إجابتك على واحد في 
  جداكثيرا  غالبا مانوعا ً قليلةمرات الإطلاقليس على الكفاءة الجسمانية 
 
 4 3 2 1 0................................................... أشعر بالوھن 1PG
 4 3 2 1 0.............................. )أحساس بالقئ( أشعر بالغثيان 2PG
لدي صعوبة في تلبية  –بسبب حالتي الصحية  3PG
 4 3 2 1 0.............................................. احتياجات أسرتي
 4 3 2 1 0....................................................... أشعر بألم 4PG
 4 3 2 1 0.................. أشعر بالضيق من الآثار الجانبية للعلاج 5PG
 4 3 2 1 0.................................. أشعر أنني عليل )مريض( 6PG
 4 3 2 1 0................................. لملازمة الفراش أنا مضطر 7PG
  جداكثيرا  غالبا مانوعا ً قليلةمرات الإطلاقليس على الكفاءة الاجتماعية و الأسرية 
 
 4 3 2 1 0.............................. أشعر أنني قريب من أصدقائي 1SG
 4 3 2 1 0....................................... أحظى بتعاطف أسرتي 2SG
 4 3 2 1 0.................................. أجد كل الدعم من أصدقائي 3SG
 4 3 2 1 0............................ أسرتي حالتي الصحية لقد تقبلت 4SG
أنѧѧا راض عѧѧن الكيفيѧѧة التѧѧي تتعامѧѧل بھѧѧا أسѧѧرتي مѧѧع  5SG
 4 3 2 1 0......................................................... مرضي
أشعر بالقرب من زوجي / زوجتي )أو الشخص الذي  6SG
 4 3 2 1 0..................................... يمثل لي الدعم الرئيسي(
بغض النظر عن حالتك الجنسية حاليا، من فضلك أجب عن ھذا السؤال. إذا كنت لا ترغب في الإجابة من  1Q
 ثم انتقل إلى السؤال التالي: فضلك ضع علامة في ھذا المربع 
 4 3 2 1 0................................ أنا راض عن حياتي الجنسية 7SG
                            63                                                             SCIRTEMOHCYSP AB-TCAF DNA AB-IBC
 
 
  .الأيام السبعة الأخيرةفي  حالتكمن فضلك ضع دائرة أو علامة على رقم واحد في كل سطر لبيان مدى انطباق إجابتك على 
  
ليس الكفاءة العاطفـــــية
على 
الإطلاق
مرات 
 قليلة
نوعا ً
 ما
كثيرا  غالبا
 جدا
 
 4 3 2 1 0.................................... أشعر بالحزن 1EG
 4 3 2 1 0.........الصحية أنا راض عن تقبلي لحالتي 2EG
 4 3 2 1 0.............أفتقد الأمل في مقاومتي لمرضي 3EG
 4 3 2 1 0..................................أشعر بالعصبية 4EG
 4 3 2 1 0...............................أنا قلق من الموت 5EG
 4 3 2 1 0..........................أخاف أن تسوء حالتي 6EG
ليس الكفاءة الوظيفيـــــــــة
على 
الإطلاق
مرات 
 قليلة
نوعا ً
 ما
كثيرا  غالبا
 جدا
 4 3 2 1 0..................................................... (المنزل العمل في أنا قادر على العمل )بما في ذلك  1FG
 4 3 2 1 0.....عملي في المنزل( يرضيني ذلك عملي )بما في 2FG
 4 3 2 1 0.........................أنا قادر على الاستمتاع بالحياة 3FG
 4 3 2 1 0.........................................لقد تقبلت مرضي 4FG
 4 3 2 1 0.................................................... أنام جيدا 5FG
 4 3 2 1 0..................أقوم بھا للترفيهأستمتع بالأشياء التي  6FG
 4 3 2 1 0.......................أنا راض عن طبيعة حياتي الآن 7FG
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 حالتكمن فضلك ضع دائرة أو علامة على رقم واحد في كل سطر لبيان مدى انطباق إجابتك على 
  .الأيام السبعة الأخيرةفي 
 
         اھتمامات إضافية  
   
ليس 
على 
الإطلاق
مرات 
 قليلة
نوعا ً
 ما
كثيرا  غالبا
 جدا
  4  3  2  1  0.................أعاني من نوبات ضيق تنفس 1B
  4  3  2  1  0...................أشعر بحرج بسبب ملابسي 2B
أحد ذراعّي أو كلاھما متورم أو حساس  3B
.............................................. للغاية
  4  3  2  1  0
 
 
 
 4B
إذا كنت لا ترغب في الإجابة من فضلك 
ثم انتقل  ضع علامة في ھذا المربع 
 إلى السؤال التالي:
  4  3  2  1  0................ جذاب/جذابة جنسيا ً أشعر أنني 
  4  3  2  1  0........................يضايقني سقوط شعري 5B
أشعر بالقلق من احتمال أن يصاب أفراد  6B
آخرون من أسرتي يوما ًما بنفس المرض 
  4  3  2  1  0......................................... الذي لدي
  4  3  2  1  0.أشعر بالقلق من تأثير التوتر على مرضي 7B
  4  3  2  1  0.....................يزعجني التغير في الوزن 8B
  4  3  2  1  0............قادرة على الشعور بأني امرأةأنا  9B
ھناك أجزاء معينة من جسمي أشعر فيھا  2P
................................................ بألم
  4  3  2  1  0
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Appendix D 
Data Collection Protocol 
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Data collection protocol 
1) Assemble Supplies  
 
 Cancer Behavior Inventory-Brief Arabic (CBI-BA) 
 Functional Assessment of Cancer Therapy-Breast Arabic (FACT-BA) 
 Informed consent document (IFC) in Arabic 
 Pencils (2) 
 Pencil sharpener 
 4 envelopes (IFC, CBI-BA, FACT-BA, and Completed) 
 Clipboard  
 Notebook 
 Eraser 
 Pen 
 Stapler   
 
2) Instrument Testing Steps 
 
1. Go to outpatient clinic in oncology center. 
2. Meet the oncologists responsible for cancer cases. 
3. Introduce self. 
4. Explain the purpose of the study to the oncologist:  “I am testing Arabic versions 
of the Cancer Behavior Inventory – Brief and the Functional Assessment of 
Cancer Therapy – Breast. My population is patients with cancer, and I’m 
particularly interested in studying women with breast cancer.” 
5.  Ask the oncologist to inform patients of the study.  
6. Meet the patient and introduce self. 
7. Give volunteer the IFC to read, then review the content with the volunteer and 
explain the purpose of the study to the participant (in Arabic). 
8. After consent to participate is obtained, say: “Thank you for your willingness to 
take part in this study. All of the information you will provide will be confidential 
and will be used only for research purposes. I translated a questionnaire that is 
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used to measure self-efficacy for coping with cancer. Your responses will help us 
understand how you cope with cancer. I will be sitting beside you. If you have 
difficulty understanding any question, you can ask me.” For women with breast 
cancer, I will add “You are asked to fill out a second questionnaire about quality 
of life in women with breast cancer.”  For those selected for cognitive 
interviewing, I will add “We would like to know what you thought about the 
questions on the CBI-BA. Are you willing to review each question and your 
response with me?”  
9. Open the envelope that contains the CBI-BA for all participants and FACT-BA for 
participants with breast cancer, attach the instrument(s) to the clipboard, and give 
to participant with pencil.   
10. Say, “Please answer each question and let me know when you are done.” 
11. Ask the participant if he/she has any questions. 
12. For the 30 participants selected for cognitive interviewing, go through each item 
of the CBI-BA and ask the participant to respond to the following questions:  
a. What did this question mean to you? 
b. Why did you select this answer? 
c. Can I rephrase this question to make it easier to understand? If so, 
how? 
13. Thank the participant. 
14. Staple instruments from the same participant together. 
15. Place the instrument(s) in the “completed” envelope. 
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16. Write the participant’s comments and recommendations in the notebook with the 
pen.  
17. Enter responses to the instruments into SPSS database. 
18. Compute Cronbach’s alpha for the CBI-BA (all participants and women with 
breast cancer separately).  
19. Address reversed scores and missing values based on guidelines for scoring the 
FACT-B available at www.facit.org  
20. Compute Cronbach’s alpha for the FACT-BA. 
21. Conduct exploratory factor analysis with principal axis factoring for the CBI-BA 
(all participants and women with breast cancer separately).  
22. Conduct exploratory factor analysis with principal axis factoring for the FACT-
BA. 
23. Collate participant comments from the cognitive interviews by item. 
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Appendix E 
Data Collection Form for Cognitive Interviews 
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Data Collection Form for Cognitive Interviews 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item Number of 
correct 
explanations 
Number of wrong 
explanations 
Recommended      
paraphrasing 
and comments 
1. Maintain self-
reliance 
   
2. Maintain a positive 
attitude 
   
3. Maintain a sense of 
humor 
   
4. Express feelings 
about the disease 
   
5. Talk about things on 
my mind at times  
   
6. Maintain activities 
(work, home, 
hobbies, social) 
   
7. Try to be calm 
throughout 
treatments and not 
allow scary thoughts 
to upset me 
   
8. Actively participate 
in treatment 
decisions 
   
9. Ask physician 
questions 
   
10 Seek support from 
others such as 
family, friends, 
groups, and 
organizations               
   
11 Share my worries or 
concerns with others 
   
12 Manage nausea and 
vomiting (whether 
or not I have had 
these problems in 
the past) 
   
13 Cope with physical 
difficulties 
   
14 Try to be calm while 
waiting one hour or 
more for my 
appointment 
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Consent Form 
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Consent Form to Participate in Research 
Psychometric Performance of Arabic Versions of the Cancer Behavior Inventory- Brief and  
Functional Assessment of Cancer Therapy-Breast  
HSC-SN-14-0265 
Part 1: English version Dialog for consent discussion. This will be read to participants 
and they will be allowed adequate time for questions regarding the study.  
Part 2: Arabic version contains equivalent information as included in Part 1 of this 
document. This section is the Letter of Notification and will be attached as a cover 
letter to the questionnaires. The intent is to supply the participants with both an oral 
and a written version of the consent information. The participants will remove and 
retain the Letter of Notification at the time of the consent discussion. By reading the 
Letter and completing the questionnaires, the participants will be giving verbal 
consent.  
INVITATION TO TAKE PART 
You are invited to take part in the study “Psychometric performance of Arabic 
versions of the Cancer Behavior Inventory-Brief and Functional Assessment of 
Cancer Therapy-Breast Cancer.” The study is also known by the shorter name “CBI-
BA and FACT-BA Psychometrics.” Maaidah Algamdi MSN, RN, a PhD student at 
the University of Texas Health Science Center at Houston (UTHSC-H), is the study’s 
principal investigator. The study is being supervised by Sandra K. Hanneman, PhD, 
RN, FAAN, and Diane W. Wardell, PhD, RN, who are the faculty advisors. This 
research project has been reviewed by the Committee for Protection of Human 
Subjects (CPHS) of UTHSC-H as HSC-SN-14-0265. 
Your decision to take part is your choice. You may refuse to take part or choose to 
stop from taking part for any reason at any time. You may refuse to answer any 
question asked or written on any forms.      
PURPOSE 
The purpose of this study is to assess how well two questionnaires work. In other 
words, do they provide reliable responses and elicit the information they are intended 
to measure? The Arabic translations of the Cancer Behavior Inventory-Brief and the 
Functional Assessment of Cancer Therapy-Breast Cancer are the two questionnaires. 
Approximately 370 Arabic-speaking adults, 18 – 75 years old, diagnosed with cancer, 
and able to read and write will take part in this study.  
PROCEDURES 
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If you decide to take part in this study, you will be asked to fill out one or two (if your 
diagnosis is breast cancer) questionnaire(s). The first questionnaire has 14 items and 
asks about how well you think you are coping with cancer; every participant will be 
asked to fill out this questionnaire. If you have been diagnosed with breast cancer, 
you will be asked to fill out the second questionnaire, which has 37 items and asks 
about your quality of life. Also, 30 of the 370 participants will be picked by chance 
(like a coin toss) and asked to review the coping questionnaire questions with the 
principal investigator to help evaluate how well the Arabic version of the coping with 
cancer questionnaire has been translated from English to Arabic.  
TIME COMMITMENT: 
Filling out the coping with cancer questionnaire will take less than 5 minutes of your 
time. Filling out the quality of life questionnaire will take less than 10 minutes of 
your time. If you are chosen for the questionnaire review with the principal 
investigator, that will take about 15 minutes.   
KNOWN RISKS AND/OR DISCOMFORTS 
There are no risks or discomforts associated with this study. 
BENEFITS 
There is no benefit to you from taking part in this study. The information we learn 
may benefit the care of future Arabic-speaking patients with cancer.  
ALTERNATIVES The alternative is not to take part in the study. 
STUDY WITHDRAWAL  
Your taking part in this study is voluntary. You may decide not to take part. If you do 
take part, you may drop out of the study at any time. Not taking part or dropping out 
of this study will involve no penalty and will not affect your health care.  
COSTS, REIMBURSMENT AND COMPENSATION 
There is no cost and you will not be paid to take part in this study.  
IN CASE OF INJURY 
If you suffer any injury as a result of taking part in this research study, please 
understand that nothing has been arranged to provide free treatment of the injury or 
any other type of payment. However, all needed facilities, emergency treatment and 
professional services will be available to you, just as they are to the community in 
general. Please report any injury to Maaidah Algamdi at 0560091866 and to the 
Committee for the Protection of Human Subjects at +1 (713) 500-7943. You will not 
give up any of your legal rights by signing this consent form. 
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CONFIDENTIALITY  
Only your age, gender, and type of cancer will be collected. Your name or other 
personal information will not be requested.  
QUESTIONS 
Please be sure that all of your questions about the study have been answered. If you 
have questions at any time about this research study, please contact the Principal 
Investigator, Maaidah Algamdi, at 0560091866. 
CPHS STATEMENT  
This study (HSC-SN-14-0265) has been reviewed by the Committee for the 
Protection of Human Subjects (CPHS) of the University of Texas Health Science 
Center at Houston.  
If you have questions about your rights as a research participant in this study, call the 
CPHS Office at +1(713)-500-7943. You will receive this consent form if you 
participate in the study. For any questions about research subjects’ rights, or to report 
a research-related injury, call the CPHS at +1 (713) 500-7943. 
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-لاج السرطانعلوظيفي التقييم الجرد سلوك السرطان ومختصره لصدارات العربية في نشرة اللإالأداء السيكومتري ل
 سرطان الثدي
 5620‐ 41 ‐NS ‐CSH
 دعوة للمشاركة
وك جرد سلمختصره لنشرة الللمتري من الإصدارات العربية سيكوالأداء ال دراسة قياسأنت مدعو للمشاركة في 
  الثدي سرطان–علاج السرطان لوظيفي التقييم الالسرطان و
    )الاداء السيكومتري لقصرالأسم بالا همعروفوھي    AB‐ TCAF و AB‐ IBC(
ستن, ماجستير الباحث الرئيسيي لھذه الدراسه :معيضة الغامدي, طالبة دكتوراة في جامعة تكساس للعلوم الصحية في ھيو
ضه ممرضه قانونية. ويتم الاشراف عليھا من قبل د. ساندرا ھانيمان , دكتوراه في التمريض وممرفي التمريض و
ه قانونيه) قانونيه) جامعة تكساس للعلوم الصحية في ھيوستن( والدكتوره ديان واردال  , دكتوراه في التمريض وممرض
البحثي  ھذا المشروع روجعوقد .التدريس  أعضاء ھيئةجامعة تكساس للعلوم الصحية في ھيوستن( وھمااستشاريتان و
 من قبل لجنة حماية الإنسان 
رفض الإجابة  وبامكانكمفي أي وقت.  و لأي سبب . بامكانكم رفض المشاركه او التوقف مقراركم للمشاركة ھو اختيارك
 على نجاح العمللغرض من ھذه الدراسة ھو تقييم مدى شكل سواء شفھيا اوكتابيا أي في   موجه لكم عن أي سؤال
الترجمات  ھل توفر اجابات الاستبيانات معلومات موثوق بھا  تھدف الى قياس ما يجب قياسه؟. وبعبارة أخرى ،ناستبيانا
نتطلب الى   في ھذه الدراسة وللمشاركهلعلاج سرطان الثدي ،  و التقييم الوظيفي  السرطان مريض سلوك العربية لجرد
على ين ، وقادر قدتم تشخيصھم بالسرطان سنة ، 57 - 81 بعمرباللغة العربية ، ينناطقمن البالغين ال 184رب اما يق
  القراءة والكتابة. 
)إذا كان التشخيص ھو سرطان الثدي(. استبيان او اثنان إذا قررت المشاركة في ھذه الدراسة ، سوف يطلب منك ملء  
ھذا الاستبيان . إذا  ملءلسرطان ، وسيتم طلب كل مشارك مع ا ة تعاملككيف و يسأل عنعنصرا  41الاستبيان الأول له 
و يسأل عن  عنصرا 73سرطان الثدي، سوف يطلب منك ملء الاستبيان الثاني ، والذي لديه ب ككنت قد تم تشخيص
 مطلب منھيو شوائيا من المشاركين ع  184من اصل 03، سيتم اختيار  اضافه الى ذلكنوعية الحياة الخاصة بك . 
ترجمة النسخة توافق للمساعدة في تقييم مدى  وذلك الباحث الرئيسي " مع استبيان التعامل مع السرطان"مراجعة اسئلة 
 .نسخه الانجليزيةالعربية من التعامل مع ال
ملء استبيان نوعية الحياة تستغرق أقل من  ودقائق من وقتك.  01مع السرطان أقل من  ستبيان التعاملستغرق ملء اي
  .دقيقة 51لي قيقة من وقتك. إذا كنت يتم اختيار لاستعراض الاستبيان مع الباحث الرئيسي ، من شأنھا أن تأخذ حواد51
مات المعلولكن  مخاطر أو مضايقات مرتبطة بھذه الدراسة ليس ھناك فائدة لكم من المشاركة في ھذه الدراسةلا يوجد 
ي ھذه الدراسة ھو ف المشاركهبالعربية في المستقبل  ينان الناطقرعاية مرضى السرط في  قد تفيد التي سنحصل عليھا 
دم تترتب اي عقوبه من ع لاحيث  من الدراسة في أي وقت  بامكانك الانسحابقد تقررعدم المشاركة .  و طوعيت
  بأي حال من الاحوال.الرعاية الصحية الخاصة بك  المشاركه او الانسحاب من الدراسه ولن تتأثر
أي شيء لتوفير  تم ترتيبي لمفي ھذه الدراسة البحثية ، عليك أن تعلم أنه  كاني من أي إصابات نتيجة مشاركتإذا كنت تع
لطوارئ العلاج المجاني للإصابة أوأي نوع آخر من الدفع. ومع ذلك ، فإن جميع التسھيلات اللازمة والعلاج في حالات ا
  كل عام.تكون متاحة لك ، تماما كما ھي بالنسبة للمجتمع بشس
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  في حالة الاصابه يرجى ابلاغ معيضة الغامدي على   6681900650
   نموذج. الوسوف لن تتخلى عن أي من حقوقك القانونية من خلال التوقيع ھذا   الانسانلجنة حماية  وابلاغ
  لن يطلب اسمك أو معلومات شخصية أخرى. فقط و وسيتم جمع العمر والجنس ، و نوع  السرطان
  تم الرد عليھا. قد من أن جميع أسئلتك حول الدراسةيرجى التأكد 
 بيان SHPC
قد روجعت من قبل لجنة حماية الانسان في مركز العلوم الصحية في جامعة   )5620‐ 41 ‐NS ‐CSH (ھذه الدراسه
 )SHPC(إذا كان لديك أسئلة حول حقوقك كمشارك البحث في ھذه الدراسة ، الاتصال بمكتببھيوستن  تكساس 
للاجابةعلى اي  وسوف تحصل على نسخه من نموذج الموافقه في حالة مشاركتك في الدراسة.   0053493171+على
 الاتصال بمكتباسئله بخصوص حقوقكم كمشاركين في الدراسه اوفي حالة الاصابه الناجمه عن المشاركه يرجى 
  0053493171+على  )SHPC(
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Abstract 
Purpose: To test psychometric performance of the Cancer Behavior Inventory - Brief 
Arabic (CBI-BA), including semantic equivalence of the CBI-BA with the original 
English version (CBI-B), and the Functional Assessment of Cancer Therapy- Breast 
Arabic (FACT-BA).  
Methods: Using a cross-sectional design, 438 patients with a cancer diagnosis in Riyadh, 
Saudi Arabia completed the CBI-BA, 30 of whom completed cognitive interviews about 
the CBI-BA. A subsample 167 women with breast cancer also completed the FACT-BA. 
Internal consistency evidence was assessed with Cronbach’s alpha (α) and construct 
validity with principal axis factoring. 
Findings: Internal consistency estimates were acceptable for the CBI-BA (α = .79 -.80) 
and the total FACT-BA (α = .88) scales, but variable for the FACT-BA subscales (α= .63 
- .89).  Exploratory factor analyses showed evidence of construct validity for the CBI-
BA; one factor was derived, compared with four in the CBI-B. Cognitive interviews 
indicated satisfactory semantic equivalence of the CBI-BA with the CBI-B. The Breast 
Cancer subscale of the FACT-BA had inadequate α and a low response rate, which 
precluded testing construct validity. The Arabic version of the general FACT-G scale 
(FACT-GA) had four factors, according to expectation, in Arabic women with breast 
cancer. 
Conclusions: The CBI-BA has adequate psychometric performance to measure self-
efficacy for coping with cancer in Arabic patients. The FACT-GA, but not the FACT-
BA, has adequate evidence of reliability and validity to measure quality of life in Arabic 
women with breast cancer.  
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Clinical Relevance: The availability of culturally sensitive and psychometrically sound 
instruments for the Arabic population diagnosed with cancer should be valuable for 
health care clinicians and researchers.       
Keywords: cancer patients, Cancer Behavior Inventory-Brief, cognitive interview, 
Functional Assessment of Cancer Therapy, quality of life, reliability, self-efficacy for 
coping, validity, women with breast cancer 
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Introduction 
A substantial health problem around the world, cancer is the second leading cause 
of death in the United States and the fourth in Saudi Arabia (Siegel, Miller & Jemal, 
2015; World Health Organization, 2014). Cancer is a condition that requires coping with 
a new life that includes changes in health behaviors (Hoffman, Lent & Raque-Bogdan, 
2013). Individuals’ internal beliefs about their health-related activities guide them to 
execute certain behaviors or change particular habits to maintain their health. Bandura 
(1977) posited that the nature of humans involves interactions among the individual’s 
beliefs, behaviors, environment, and cognition. These interactions direct subsequent 
changes in human behavior. Bandura (1993) defined self-efficacy as a person’s beliefs in 
his or her capabilities to control level of function within the surroundings that influence 
the person’s life. Lev (1997) used Bandura’s Theory of Self-efficacy to illustrate the role 
of self-efficacy for coping (SEC) with cancer in behavioral adaptation. Barlow (2010) 
suggested that self-efficacy enhances health status outcomes. SEC is an important attitude 
to assess in patients with cancer so that interventions may be designed to increase low 
levels or maintain high levels of SEC with cancer. Assessment of SEC in Arabic 
populations requires the availability of psychometrically sound instruments.  
Bandura’s (2002) description of how the complexity of culture shapes human 
behavior led to the importance of considering Arabic culture in testing SEC with cancer, 
which can be measured with the Cancer Behavior Inventory-Brief (CBI-B), based on the 
Theory of Self-efficacy. Verbatim translation of an instrument is insufficient for ensuring 
the intended meaning of the instrument’s items. Reeve et al. (2011) suggested that 
cognitive interviewing provides an in-depth method of detecting cognitive issues with the 
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phrasing of items in a translated instrument. Validity depends on the translated 
instrument being semantically equivalent to the original one. Cognitive interviewing 
helps ensure that the translation is both culturally appropriate and captures the concept(s) 
intended for measurement with the original instrument (Beck, Bernal, & Froman, 2003).  
Lev et al. (2001) observed a significant improvement in the quality of life (QOL) 
of women with breast cancer after enhancing self-efficacy with an intervention. Women 
with high SEC with breast cancer tend to engage in positive behaviors that reflect high 
QOL (Heitzmann et al., 2011). Heitzmann and colleagues conceptualized QOL as 
physical, emotional, family/social, and functional well-being, consistent with others’ 
conceptualization of QOL as a multidimensional construct (Bader & Kerbs, 2012; Chen, 
Weiss, Heyman, Cooper, & Lusting, 2010). Chen et al. added a disease component to the 
definition of QOL (perceived health and disease), indicating that the disease itself could 
be considered an essential aspect. Others have promulgated that QOL also can be 
determined by socio-demographic characteristics, disease, and treatment outcomes 
(Yang, Brother, & Anderson, 2008). 
Women with breast cancer face several issues throughout the course of diagnosis, 
treatment, and recovery (DiSipio, Hayes, Newman, & Janda, 2009; Watson, Homewood, 
& Haviland, 2012) that can negatively affect QOL and survival (Watson, et al.).  Some 
women with breast cancer experience poor QOL due to an inability to cope with their 
illness (Akin, Can, Durna, & Aydiner, 2008). Arabic women with breast cancer face 
additional issues associated with stigma, fear, and anxiety that influence the woman’s 
abilities to cope with breast cancer (Alam, 2006; Al-Zaben, Sehlo, & Koenig, 
2015;Amin, Almulhim & Almeqihwi, 2009; Donnelly et al., 2013; Sarhan, 2009), and 
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consequently affect QOL. The Functional Assessment of Cancer Therapy-Breast (FACT-
B), a measure of QOL for women with breast cancer (Brady et al., 1997), has been 
translated into Arabic (available at: http://www.facit.org/FACITOrg/Questionnaires).  
The Cancer Behavior Inventory-Brief Arabic (CBI-BA) was recently developed 
to measure SEC with cancer in the Arabic-speaking population (Algamdi & Hanneman, 
in press-a). Preliminary evidence for internal consistency reliability of the CBI-BA was 
tested with 97 Arabic-speaking patients with cancer in Houston, Texas, USA; Cronbach’s 
alphas were ≥ .76 (Algamdi & Hanneman, in press-b), indicating adequate reliability 
estimates for a new instrument (Nunnally & Bernstein, 1994).  No evidence of reliability 
was located for the FACT-BA, so internal consistency of the FACT-BA scale and 
subscales in Arabic-speaking women with breast cancer in Houston was tested. 
Cronbach’s alpha for the total scale was .91, but subscale alphas varied from .43 - .89 
(Algamdi & Hanneman, in press-b).  
Study Aims 
The purpose of the present study was to test the psychometric performance of the 
CBI-BA and the FACT-BA in the Arabic-speaking population in Saudi Arabia. 
Randomly selected participants also participated in cognitive interviews to determine the 
semantic equivalence of the CBI-BA with the CBI-B. The study aims were to evaluate in 
Arabic outpatients with cancer evidence for: (1) internal consistency reliability of the 
CBI-BA using Cronbach’s alpha (α), (2) validity of the CBI-BA using exploratory factor 
analysis (EFA) and cognitive interviewing; (3) internal consistency reliability of the 
FACT-BA using α; and (4) validity of the FACT-BA using EFA. Aims 3 and 4 were 
tested only with women with breast cancer.  
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Methodology 
Design, Sample, and Setting 
 The study was approved as exempt from review by the University of Texas 
Health Science Center at Houston Committee for the Protection of Human Subjects and 
by King Fahad Medical City and Prince Sultan Medical Military City oncology centers. 
Using a cross-sectional design, 443 adults with a diagnosis of cancer were recruited from 
two oncology centers located in Riyadh, Saudi Arabia. Oncologists at the two centers 
were asked to notify patients of the study at the patient’s regular appointment time, and a 
snowball sampling technique (Polit & Beck, 2012) was used to generate the convenience 
sample. After providing informed consent, all participants were asked to complete the 
CBI-BA; of these, 30 participants were randomly selected to participate in cognitive 
interviews about the CBI-BA.  From the pool of all participants, those diagnosed with 
breast cancer were asked to also complete the FACT-BA.  
Instruments 
The CBI-BA is a 14-item, self-report, norm-referenced, paper-and-pencil 
instrument that takes ≤ 5 minutes to complete. This instrument was developed to measure 
SEC with cancer in the Arabic-speaking population (Algamdi & Hanneman, in press-a), 
and is a translation of the 14-item CBI-B posted for public use 
(http://psychooncologynd.com/).  
The CBI-B is the result of a sequence of versions that started with 43 items and 
ended with 12 items. Originally, Merluzzi, and Martinez Sanchez (1997) developed the 
Cancer Behavior Inventory (CBI) with 43 items (version 1.0). Factor analysis with a 
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sample of 502 patients with cancer produced six factors: (1) maintaining activity and 
independence, (2) coping with treatment-related side effects, (3) 
accepting cancer/maintaining positive attitude, (4) seeking and understanding medical 
information, (5) affective regulation, and (6) seeking support. Merluzzi et al. (2001) 
reduced the items of this long scale to 33 and added a stress management subscale 
(version 2.0), which was tested with 280 cancer patients. Factor analysis yielded seven 
factors: (1) maintaining activity and independence, (2) seeking and understanding 
medical information, (3) managing stress, (4) coping with treatment-related side-effects, 
(5) accepting cancer/maintaining positive attitude, (6) affective regulation, and (7) 
seeking support. Heitzmann et al. (2011) developed a brief version of the CBI (CBI-B) 
and conducted multiple exploratory and confirmatory factor analyses with data from 
three samples of 735, 199, and 370 patients with cancer. The results varied, but the 
optimal solution had 12 items loaded on 4 factors: (1) maintaining independence and 
positive attitude, (2) participating in medical care, (3) coping and stress management, and 
(4) managing affect. Although confirmatory factor analyses conducted by Heitzmann and 
colleagues showed optimal statistical fit indices for a 12-item CBI-B, the 14-item CBI-B 
in the public domain was translated into Arabic, assuming that the extra two items might 
serve the construct validity of the Arabic version and psychometric testing could be done 
with both the 14- and 12-item brief versions.  
The CBI-BA uses a 9-point, Likert-type scale (1 = not at all confident, 9 = totally 
confident). The sum of the item scores indicates the level of SEC, with higher scores 
reflecting a stronger SEC than lower scores (Heitzmann et al., 2011). Demographic data 
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of age, gender, and type of cancer diagnosis were added to the CBI-BA for a description 
of the sample.  
The FACT-BA is a 37-item, self-report, norm-referenced, paper-and-pencil 
instrument developed to measure QOL of Arabic women with breast cancer over the past 
7 days; it takes about 10 minutes to complete. The original FACT-B (Brady et al., 1997) 
consists of the Functional Assessment of Cancer Therapy-General (FACT-G) scale, with 
four subscales, and an additional breast cancer subscale, labeled “Additional Concerns,” 
that was added to serve special concerns of the breast cancer population.  The subscales 
are Physical Well-being (PWB), Social Well-being (SWB), Emotional Well-being 
(EWB), Functional Well-being (FWB), and Additional Concerns (Breast Cancer 
subscale). The FACT-BA uses a 5-point Likert-type scale, scored from 0 (not at all) to 4 
(very much). After reverse-scoring 20 items, the item scores are summed. Higher total 
FACT-BA scores indicate better quality of life than lower scores.   
Data Collection 
Data were collected between March and July 2015. Before data collection 
commenced, 30 numbers were generated randomly by computer. Participants with study 
identification codes that matched the randomly generated numbers were invited to 
participate in cognitive interviews, after completing the CBI-BA, to determine semantic 
equivalence of the CBI-BA items. The participants selected for cognitive interviewing 
were asked the following questions about each item on the CBI-BA: (a) What did this 
question mean to you? (b) Why did you select this answer? (c) Can I rephrase this 
question to make it easier to understand? If so, how? The participants’ responses were 
recorded manually. Women with breast cancer who completed the CBI-BA were asked to 
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complete also the FACT-BA, regardless of whether or not they had participated in 
cognitive interview. Administration of the instrument(s) and cognitive interviews were 
conducted in Arabic in a private area of the oncology center by the author.   
Data Management and Analysis 
Responses to the instruments were entered into an Excel database and imported 
into SPSS statistical software (version 23, IBM Corp. Armonk, NY). Data analysis 
included descriptive statistics, Cronbach’s alpha for internal consistency reliability, and 
EFA with Principal Axis Factoring (PAF) and both orthogonal (Varimax) and oblique 
(Promax) rotations for construct validity. The distribution of data was assessed using 
histogram and the Kolmogorov-Smirnov normality test. Missing values were handled 
using the imputation method (Donders, van der Heijden, Stijnen, & Moons, 2006). When 
inter-item correlation was ≥ .3, the missing value was replaced by the average score of 
the participant’s responses for all other items. If inter-item correlation was < .3, 
imputation was not used and the item was treated as a missing value. 
Cronbach’s alpha for the CBI-BA was computed for all participants with cancer 
and, separately, for women with breast cancer; Cronbach’s alpha for the FACT-BA was 
computed for women with breast cancer. The criterion for adequate evidence of internal 
consistency was Cronbach’s α ≥ .70 (Nunnally & Bernstein, 1994). 
Separate EFAs were conducted for the CBI-BA for all participants with cancer 
and for women with breast cancer, and for the FACT-BA for women with breast cancer. 
The scree plot, testing eigenvalue departure from linearity (Williams, Brown, & Onsman, 
2012), was used to determine the number of factors extracted. A priori criteria for an 
acceptable solution included factor loadings ≥ .30, cross-loadings > .20, and ≥ 3 items per 
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factor (Leech, Barrett & Morgan, 2011; DeVellis, 2012). Based on the hypothesized 
subscales and the a priori criteria, a 3-factor solution for the CBI-BA and a 5-factor 
solution for the FACT-BA were expected. A 3-factor, in contrast to 4-factor, solution was 
expected for the CBI-BA because only two items loaded on Factor 2 (participating in 
medical care) in the Heitzmann et al. (2011) optimal solution. 
  Participants’ comments from the cognitive interviews were collated and described 
by CBI-BA item. The criterion for future revision was more than nine constructive 
comments per item; nine or more comments indicated that ≥ 30% of participants had 
difficulty with the item. Fewer than nine constructive comments, with an acceptable 
explanation of the response choice, indicated acceptable semantic equivalence of the 
CBI-BA item with the CBI-B.  
Results 
Of the 443 participants recruited, 438 (98.8%) completed the CBI-BA. Of the 438 
who completed the CBI-BA, 168 were women with breast cancer, 167 (99.4%) of whom 
completed the FACT-BA. Thirty participants completed the cognitive interview. 
Sociodemographic characteristics of the sample are presented in Table 1.  
The internal consistency estimates for the CBI-BA (patients with cancer and 
women with breast cancer) and the FACT-BA (women with breast cancer) are reported in 
Table 2. The mean inter-item correlation was .23 for the CBI-BA and .18 for the FACT-
BA. Total scores of the CBI-BA were negatively skewed; median (and interquartile 
range) was 95 (82), with minimum and maximum values of 44 and 126, respectively. 
Total scores for the FACT-BA were normally distributed; mean (േSD) was 99.7 (േ 21), 
with minimum and maximum values of 33 and 140, respectively. Out of 167 women with 
breast cancer, 111 women did not respond to item 4 in the breast cancer subscale; the 
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inter-item correlation was .14, which was lower than the .3 a priori criterion for missing 
value imputation.  
For the CBI-BA EFA in cancer patients, the subject-to-item ratio was 31:1. The 
Kaiser-Meyer-Olkin (KMO) test was .848, indicating adequacy of the sample to conduct 
factor analysis, and the Bartlett test (p < .001) indicated that the correlation matrix and 
identity matrix were significantly different (Leech, Barrett & Morgan, 2011). Inspection 
of the scree plot showed that eigenvalues departed from linearity with two factors (Figure 
1), which explained 36.4% of the total variance. Table 3 shows factor loadings of CBI-
BA items for the total sample of cancer patients (N=438); 12 of 14 items loaded on 2 
factors, with 7 items loading on Factor 1 and 2 items loading on Factor 2, according to 
the a priori criteria for factor loading and cross-loading. Factor 2 did not meet the a priori 
criterion for number of items loaded. Acceptable reliability evidence was maintained with 
a 7-item scale, with Cronbach’s alpha of .81(Table 2), and inter-item correlation 
increased from .23 to .38.    
For women with breast cancer, the subject-to-item ratio was 12:1. The KMO 
measure of sampling adequacy was .805 and the Bartlett test was significant (p = 001). 
The scree plot (Figure 2) showed a departure from linearity with 4 factors that explained 
47.5% of the variance. Table 4 shows factor loadings of CBI-BA items for the subsample 
of women with breast cancer (n=168); 11 of 14 items loaded on 4 factors with 7 items 
loading on Factor 1, 2 items on Factor 2, and 1 item each on Factors 3 and 4, according to 
the a priori criteria for factor loading and cross-loading. Factors 2, 3, and 4 did not meet 
the a priori criterion for number of items loaded.  Acceptable reliability evidence was 
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maintained with a 7-item scale, with Cronbach’s alpha of .83 (Table 2), and inter-item 
correlation increased from .24 to .40.     
Table 5 presents the results of cognitive interviews with 30 participants about 
their understanding of CBI-BA items. Every participant correctly understood items 12 
and 14. The number of incorrect interpretations of the remaining 12 items varied from 1 
to 7, which did not meet the threshold for item revision.   
For the FACT-BA in women with breast cancer (n=56), the subject-to-item ratio 
was 1.5:1. Although the Bartlett's Test of Sphericity was significant (p=.000), the KMO 
test was .577, indicating the sample was inadequate for factor analysis. The scree plot 
(not shown) showed departure from linearity with 11 factors, which explained 66.8% of 
the total variance.  When the Additional Concerns subscale was excluded, the sample size 
was 167, with a subject-to-item ratio of 6:1. The KMO measure of sampling adequacy 
was .846 with significant Bartlett's Test of Sphericity (p=.000). The scree plot showed 
departure from linearity with 6 factors (Figure 3); a 6-factor solution explained 54.1% of 
the total variance. Table 6 shows loading of 7 items on Factor 1, 6 items on Factor 2, and 
5 items each on Factors 3 and 4. Factors 5 and 6 had an insufficient number of item 
loadings to constitute a factor according to the a priori criterion. 
Discussion 
The sample for this study was 438 Arabic-speaking adult men and women 
diagnosed with cancer and recruited from two cancer centers in Riyadh, Saudi Arabia. 
Three-quarters of the sample was female and the average participant was middle-aged. 
Consistent with the skewed gender distribution, 38% of the sample had a diagnosis of 
breast cancer. Other common cancer diagnoses were gastrointestinal and hematologic. 
The psychometric properties of the CBI-BA were assessed in the general cancer 
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population and in women with breast cancer with both 14- and 12-item versions. 
Cognitive interview about the meaning of CBI-BA items was evaluated in 30 participants 
randomly selected from the total sample. The FACT-BA was tested for reliability and 
validity evidence in 167 women with breast cancer.  
Although the reliability estimate (α ≥ .78) for the CBI-BA in Arabic general 
cancer patients was lower than α estimates (.84 - .88) of the CBI-B in English-speaking 
general cancer patients (Heitzmann et al., 2011; Merluzzi, Nairn, Hegde, Martinez 
Sanchez, & Dunn, 2001), the estimate exceeded the a priori criterion and is considered an 
acceptable level of internal consistency for a newly-developed instrument (Nunnally & 
Bernstein, 1994). The same is true in Arabic women with breast cancer (α ≥ .79).  
Average inter-item correlations in both the total sample and the subsample were 
marginally higher with the 12-item CBI-BA (r ≥ .24 - .26) than with the 14-item 
instrument (r < .23 - .24). Both 12-item and 14-item CBI-BA scores were skewed in the 
general cancer patients, which may have influenced the factor analysis results and, 
consequently, the evidence for construct validity of the CBI-BA. Log-linear 
transformation of the data did not affect the EFA results. 
The primary objective of EFA is to determine the minimum number of common 
factors (i.e., those that reflect shared variance with multiple items on the instrument) that 
explain the correlations in the data (Ferguson & Cox, 1993). Each item was expected to 
correlate to some degree with every other item on the CBI-BA given that the subscale 
concepts all relate to SEC with cancer. Heitzmann et al. (2011) reported a 4-factor 
solution using EFA with oblique rotation with data from a large sample (N = 735), and 
then supported their findings with confirmatory factor analysis with data from two 
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different samples (N = 199 and N = 370). However, the criterion for number of loaded 
items per factor was less than recommended (DeVellis, 2012) in Factor 3 (participation in 
medical care); two items loaded compared with the recommended three or more.  
In the present study, the Varimax method of orthogonal rotation was selected to 
provide a simple structure. Nonetheless, oblique rotation, as used by Heitzmann et al. 
(2011), was considered in repeat EFAs for the CBI-BA to see if the assumption of factor 
inter-correlations yielded a more appropriate factor solution. To determine the optimal 
factor solution for the CBI-BA in 438 Arabic-speaking cancer patients, several EFAs 
were conducted for both the 12-item CBI-BA, consistent with the optimal solution in the 
English version (Heitzmann et al.), and the publicly posted 14-item instrument translated 
into Arabic (Algamdi & Hanneman, In press-a).  EFAs for the 14-item CBI-BA, with 
both oblique and orthogonal rotations, produced a 3-factor solution with 6, 2, and 2 items 
loaded according to the a priori criteria on the three respective factors; 4 items had cross-
loadings < .20. The criterion for number of items per factor was not met for Factors 2 and 
3; therefore, only one factor with 6 items was the final solution. In the EFAs for the 12-
item instrument, oblique and orthogonal rotations yielded a 2-factor solution with 7 and 2 
items loading according to the a priori criteria; 3 items had cross loadings < .20. The 
criterion for number of items per factor again was not met for Factor 2; therefore, only 
one factor with 7 items was the final solution. Although the EFAs for the 14-item 
instrument explained marginally greater variance (37.9% vs. 36.4%), EFAs for the 12-
item instrument accounted for a slightly higher number of items (7 vs. 6). Reported here 
are the EFA findings for the 12-item instrument, to preserve a larger number of items, 
and the oblique rotation loadings, which were higher than the orthogonal rotation factor 
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loadings. Thus, the optimal solution for factor analysis of the CBI-BA is one factor, 
which is consistent with a unidimensional construct of SEC with cancer. The findings 
suggest that a 7-item CBI-BA can capture the construct adequately in the Arabic 
population.     
From a conceptual stance, the loading of 7 items on one factor makes sense. Items 
1 (maintaining self-reliance), 2 (maintaining positive attitude), 3 (maintaining sense of 
humor), 6 (maintaining activities), 7 (trying to be calm throughout treatments), 8 
(participating in treatment decisions), and 13 (coping with physical challenges) are all 
concerned with “maintaining independence and positive attitude.”  The seven items 
represent the majority of the items in the first three subscales of the CBI-B (Heitzmann et 
al., 2011).   
Items 10 (seeking social support) and 11 (sharing my worries and concerns with 
others) loaded strongly on Factor 2. Although two items are generally considered an 
inadequate number to constitute a subscale, they explained significant variance in SEC 
with coping, as shown in Figure 1. The strong (> .50), clean (i.e., no cross-loading) 
loadings of these items were unexpected. Understanding of item 10 was problematic in 
the earlier cognitive interviews during development of the CBI-BA (Algamdi & 
Hanneman, In press-a). Items 11 and 4 (cross-loaded on Factor 1) involve expressing 
feelings, which is a conservative issue in Arabic culture, especially for cancer patients 
(Qasem, 2010; Alqaissi & Dickerson, 2010). Arabs prefer to avoid talking about their 
illness from fear of being placed in a sympathetic position (Doumit, Huijer, Kelley, El 
Saghir & Nassar, 2010a). Item 12 (managing nausea and vomiting) did not meet the 
factor loading criterion. Study participant interviews revealed that nausea and vomiting 
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are perceived as side effects that do not necessarily occur in all cancer patients, and, 
therefore, patients cannot predict what their reaction would be when it happens. 
Furthermore, participants indicated that they consider all side effects as “physical 
challenges” (item 13).  
For the subsample of women with breast cancer (n=168), the same steps in 
producing an optimal EFA solution were followed as with the general cancer patients. 
Orthogonal rotation produced higher loadings than oblique, suggesting that the factors are 
not correlated (Afifi, May & Clark, 2012). EFAs for the 14-item version explained 
relatively larger variance (47.5% vs 43.5%) and produced more items (7 vs 6) than EFAs 
for the 12-item version. The optimal solution of the CBI-BA was 1 factor with 7 loaded 
items with the 14-item version, in contrast to the total sample EFA where 7 items loaded 
on the 12-item version; the item loadings were slightly different. All but one of the same 
items that loaded in the general cancer sample loaded in the subsample of women with 
breast cancer, albeit the strength of the loadings varied. Item 14 (trying to be calm while 
waiting for appointment) loaded on the factor in place of item 8 (active participation in 
treatment decisions). Participation in treatment decisions works differently in Middle-
eastern, and especially Arabic, women, who need to involve husband or family members 
in decision making (Gilbar & Gilbar, 2009; Hammad, Kysia, Rabah, Hassoun & 
Connelly, 1999); consequently, the item loaded on a separate factor. Item 14 (trying to be 
calm while waiting at least one hour for my appointment), along with items 7 (trying to 
be calm throughout treatments) and 2 (maintaining a positive attitude) may be viewed as 
positive attitude.   
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For the cognitive interview findings, the criterion for considering revision was not 
met; none of the items received more than nine constructive comments. Item 2 
(maintaining positive attitude) had seven wrong explanations and Item 10 (seeking social 
support) had six wrong explanations, both within an acceptable range.  
The total FACT-BA scale had adequate evidence of reliability. Cronbach’s alpha 
in the Arabic-speaking sample (α= .88) was somewhat lower than, but comparable with, 
estimates of internal consistency in English-speaking (Brady et al., 1997) and Persian-
speaking (Patoo, Allahyari, Moradi, & Payandeh, 2015) samples, which were .90 and .92, 
respectively. The PWB, SWB, EWB, and FWB subscales also had acceptable reliability 
estimates (.75 - .89), with subscale alphas comparable with estimates in the English- and 
Persian-speaking samples (.69 - .86 and .71 - .93, respectively). Alpha level of the 
Additional Concerns (Breast Cancer) subscale was the same (α = .63) in the Arabic-, 
English-, and Persian-speaking samples, and did not meet the a priori criterion for the 
present study. According to Brady et al. (1997), this subscale was added to the FACT-G 
to make the assessment of QOL more suitable for the breast cancer population.  
Because the Additional Concerns subscale did not have adequate reliability 
evidence and had a low participant response rate, multiple EFAs were conducted for the 
FACT-BA, with and without this subscale, using orthogonal and oblique rotations. When 
the breast cancer subscale was included, EFA solutions were unstable due to insufficient 
sample size. The low response rate in the Additional Concerns subscale was largely due 
to items 4 (I feel sexually attractive) and 9 (I am able to feel like a woman), which reflect 
femininity. Femininity is considered a private issue in the gender-constrictive Arabian 
culture (Amin, Almulhim & Almeqihwi, 2009; Sarhan, 2009). The same response 
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patterns were seen in the preliminary psychometric testing of the FACT-BA in Arabic-
speaking women with breast cancer in Houston, Texas (Algamdi & Hanneman, in press-
b), validating the cultural roots of reluctance to respond to items of a sexual nature, in 
contrast to the local environment or setting. Thus, the breast cancer subscale does not 
help determine QOL in Arabic-speaking women with breast cancer.   
The Arabic version of the FACT-G (FACT-GA), on the other hand, showed 
adequate evidence of construct validity for measuring QOL in Arabic-speaking women 
with breast cancer. Although the sample size was relatively small (n = 167), the subject-
to-item ratio in the present study (6:1) exceeds the minimum ratio recommended 
(Gorsuch, 1983). For the EFAs conducted on the FACT-GA, the data met the criterion 
for sampling adequacy (Leech, Barrett & Morgan, 2011; DeVellis, 2012). With 
orthogonal rotation, all items loaded according to theoretical expectation, except for item 
7 (I am forced to spend time in bed) of the PWB subscale, items 1 (I am able to work 
[include work at home]) and 4 (I have accepted my illness) of the FWB subscale and item 
2 (I am satisfied with how I am coping with my illness) of the EWB subscale – all of 
which showed cross-loadings on two or more factors, albeit the loadings were highest on 
the original subscale. Oblique rotation yielded a more optimal solution; all items loaded 
according to theoretical expectation except item 1 (I am able to work include work at 
home) in the FWB subscale and item 2 (I am satisfied with how I am coping with my 
illness) in the EWB subscale. Items 1 (I feel close to my friends) and 3 (I get support 
from my friends) in the SWB subscale loaded together on a separate factor with both 
rotational methods. Perhaps the latter two items concerning relationships with friends 
loaded differently from theoretical expectations because Arabian women tend to conceal 
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a breast cancer diagnosis from friends to avoid stigma (Alqaissi & Dickerson, 2010; 
Doumit, El Saghir, Abu-Saad Huijer, Kelley, & Nassar, 2010b). Arabic women with 
breast cancer disclose their diagnosis only to close relatives, and not to friends and 
extended family members (Kobeissi et al., 2014). Reliability evidence for the FACT-GA 
was adequate (Cronbach’s alpha = .89), and inter-item correlation was .26.   
The study had several limitations. Social desirability response set was not tested, 
which might have influenced the findings because the instruments are self-report 
questionnaires and participants may have selected the most favorable responses to satisfy 
the investigator (Van de Mortel, 2008). Three-fourths of the total sample was female, 
which may limit generalizing the findings to Arab males diagnosed with cancer. This 
limitation is mitigated, however, because 107 men is a large sample size. The stage of 
cancer of women with breast cancer was not investigated, and the extent and severity of 
disease may affect variation in the responses to the FACT-BA breast cancer subscale.            
Conclusions, Recommendations, and Clinical Implications 
The goal of this study was to test the psychometric performance of two Arabic 
instruments: the CBI-BA for measuring SEC with cancer and the FACT-BA for 
measuring QOL in women with breast cancer. Reliability testing indicates an adequate 
level for considering use of both instruments in future studies: the CBI-BA for all patients 
with cancer and the FACT-GA for women with breast cancer.  The CBI-BA has 
acceptable evidence of validity for Arabic-speaking cancer patients; a unidimensional 
scale with 7 items captures the construct of SEC with cancer. The FACT-BA does not 
have acceptable evidence of validity in Arabic-speaking women with breast cancer; 
however, the FACT-GA, which excludes the Additional Concerns (breast cancer) 
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subscale, does. A 23-item FACT=GA, with four subscales, captures the construct of QOL 
in Arabic women with breast cancer.  
It is recommended that items regarding intimate issues in the FACT-GA be either 
optional or excluded from the instrument due to the conservative nature of Arabic 
cultures. Further testing of the CBI-BA and FACT-GA in Arabic populations is 
recommended due to the large variation in Arabic words that can serve as synonyms for 
English words. An instrument that can be used with a large percentage of the Arabic 
population is desirable, and psychometric testing in parts of the Middle East outside of 
Riyadh is recommended.  
Concealment (i.e., reluctance to divulge) appears to influence responses to 
emotional and sexual-related concerns in the Arabic population, and this needs to be 
considered when deciding to exclude or make optional such items. Although willingness 
to address such issues may change over time, the majority of Saudi women with breast 
cancer consider these areas of women’s health to be taboo for discussion with health care 
providers or researchers. We hope this observation enlightens research and practice with 
regard to the Arabian culture. Understanding culturally-sensitive issues that need to be 
avoided would be important when dealing with cancer patients at any stage of illness. 
Clinical Resources  
 World Health Organization: 
http://www.who.int/nmh/countries/sau_en.pdf?ua=1  
 The Notre Dame Lab for Psycho-Oncology Research: 
http://psychooncologynd.com/  
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 Functional Assessment of Chronic Illness Therapy (FACIT) Measurement 
System: http://www.facit.org/FACITOrg/Questionnaires  
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Table 1 
Demographic characteristics of the total sample (all patients with cancer). 
 
All cancer patents                                                                N= 438 
Age 
Mean (±SD) 
 
48.2 (±12.8) 
Gender 
Male (%) 
Female (%) 
 
107 (24.4%) 
331 (75.5%) 
 
Diagnoses 
Breast  168 (38%) 
Digestive/gastrointestinal  68 (16%) 
Hematologic  44 (10%) 
Gynecologic  37 (8%) 
Multiple cancers  32 
Endocrine/ neuroendocrine  22 
Musculoskeletal  16 
Neurologic  15 
Respiratory/ thoracic  10 
Genitourinary  10 
Unknown primary  10 
Head & neck 5 
Otolaryngologic  1 
Total 438 
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Table 2  
Cronbach’s alpha coefficients of the Cancer Behavior Inventory-Brief Arabic (CBI-BA) 
and the Functional Assessment of Cancer Therapy-Breast Arabic (FACT-BA)   
 
 
 
 
 
 
 
 All cancer patents 
  (N=438) 
Women with breast cancer 
(n=168) 
14- item CBI-BA .79 .80 
12- item CBI-BA .78 .79 
7-item  CBI-BA .81 .83 
FACT-BA 
Without item 
7 (social) 
 (n=56) 
Without item 4 
 (concerns) 
(n= 165)  
Without 
optional items  
(n= 165) 
With optional 
items  
(n= 167) 
Total scale  .88 .89 .89 .88 
Physical Well-being 
Subscale 
- - - .86 
Social Well-being 
Subscale 
.73 - - .75 
Emotional Well-
being Subscale 
- - - .75 
Functional Well-
being Subscale 
- - - .89 
Breast Cancer Sub-  
scale (Additional 
Concerns) 
- .63 .63 .63 
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Table 3 
Rotated factor loadings from exploratory factor analysis using principal axis factoring 
with promax rotation for 12-item Cancer Behavior Inventory- Brief Arabic (CBI-BA) 
(N=438)  
 
Item Number CBI-BA Item 
Factors 
1 2 
2 Maintaining a positive attitude .761 -.064 
1 Maintaining self-reliance               .747 -.141 
6 Maintaining activities .659 -.032 
7 Trying to be calm throughout treatments and 
not allowing scary thoughts to upset me 
.600 .041 
13 Coping with physical challenges .595 -.053 
3 Maintaining a sense of humor .591 .054 
8 Actively participating in treatment decisions .443 .141 
9* Asking physicians questions .372 .334 
12 Managing nausea and vomiting (whether or 
not I have had these problems in the past) 
.293 .248 
11 Sharing my worries or concerns with others -.095 .720 
10 Seeking social support (seeking help from 
others such as family or friends 
-.095 .589 
4* Expressing feelings about the disease .228 .345 
 
Note. *Cross-loaded item.   
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Table 4 
Rotated factor loadings from exploratory factor analysis using principal axis factoring 
with varimax rotation for the 14-item Cancer Behavior Inventory-Brief Arabic (CBI-BA) 
in women with breast cancer (n=168)  
 
Item Number CBI-BA item Factor 
1 2 3 4 
2 Maintaining a positive attitude .812 .065 .195 .006 
6 Maintaining activities .681 -.043 -.072 .209 
3 Maintaining a sense of humor .668 .199 .024 .070 
1 Maintaining self-reliance               .657 .028 .163 -.016 
13 Coping with physical challenges .568 .065 .174 -.008 
7 Trying to be calm throughout 
treatments and not allowing scary 
thoughts to upset me 
.551 .083 .229 .035 
14 Trying to be calm while waiting at least 
one hour for my appointment 
.514 .058 .130 -.063 
12* Managing nausea and vomiting .358 .276 -.055 .137 
4 Expressing feelings about the disease .271 .760 .024 .092 
5 Putting things out of my mind at times -.052 .650 . 246 .052 
8 Actively participating in treatment 
decisions 
.371 .174 .756 .159 
9* Asking physicians questions .195 .310 .390 .249 
10 Seeking social support (seeking help 
from others such as family or friends)  .077 .006 .108 .695 
11* Sharing my worries or concerns with 
others -.077 .401 .089 .567 
 
Note.. *Cross-loaded item 
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Table 5 
Results of cognitive interviews (n=30) about the Arabic version of the Cancer Behavior Inventory-Brief 
Items # correct 
explanations
# wrong 
explanations 
Recommended paraphrasing   Comment 
1- Maintaining self-reliance               28 2 Rely on self or self-confidant  
2- Maintaining a positive attitude 23 7   
3- Maintaining a sense of humor 26 4   
4- Expressing feelings about the disease 28 2   
5- Putting things out of my mind at times 27 3   
6- Maintaining activities (work, home, hobbies,  
      social) 
29 1   
7- Trying to be calm throughout treatments and not   
      allowing scary thoughts to upset me 
29 1   
8- Actively participating in treatment decisions 27 3   
9- Asking physicians questions 29 1  Similar to item 8 
10- Seeking social support (seeking help from others 
      such as family or friends  
24 6 Explain type of support  Similar to item 1 
11- Sharing my worries or concerns with others 29 1    Similar to item 5 
12- Managing nausea and vomiting (whether or not I 
      have had these problems in the past) 
30 0         Change manage to deal    
        with or cope  
 
13- Coping with physical challenges 27 3    Similar to item 12 
14- Trying to be calm while waiting at least one hour 
      for my appointment 
30 0   
88 
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Table 6 
Rotated factor analysis of Functional Assessment of Cancer Therapy-Breast Arabic with 
exclusion of the Additional Concerns (breast cancer) subscale (n=167)  
 Factor 
1 2 3 4 5 6 
physical7r .762 -.085 -.112 -.021 .117 .530 
physical1r .738 -.009 .023 -.053 -.094 -.076 
physical6r .731 -.164 .265 .139 -.023 .007 
physical4r .713 .014 .095 .049 -.148 -.034 
physical3r .669 -.074 -.029 -.072 .092 .030 
physical2r .584 .091 .151 -.085 -.146 .222 
physical5r .559 -.058 .238 -.018 .096 .064 
functional7 -.170 .872 .113 .135 -.044 .038 
functional3 .046 .845 .052 -.041 -.024 .048 
functional4 -.251 .813 .105 -.131 -.018 .157 
functional6 -.009 .697 .167 -.007 .042 .092 
functional2 .321 .642 -.308 .029 .067 -.091 
functional5 .228 .463 .065 .237 -.098 .006 
function1* .433 .522 -.253 -.006 .070 -.046 
emotion4r .165 -.058 .670 -.100 .183 -.233 
emotion6r .059 .019 .651 .054 -.124 .079 
emotion1r .239 .117 .629 .000 -.006 -.062 
emotion5r -.068 .068 .549 .161 -.090 .306 
emotion3r .097 .134 .484 -.143 .174 .086 
social5 .037 -.129 -.059 .845 -.004 -.020 
social4 -.021 .090 -.049 .707 -.001 -.115 
social2 -.092 -.098 .037 .548 .263 .025 
social7 .015 .178 -.045 .476 .046 .118 
social6 -.053 .039 .225 .454 .023 -.093 
social1 .017 .001 .096 .069 .721 .052 
social3 -.116 .010 -.058 .113 .678 .151 
emotion2* -.090 .368 .073 -.117 .164 .405 
 
Note. *Cross-loaded item; r, reverse-scored. 
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Figure 1. Scree plot for exploratory factor analysis of the Cancer Behavior Inventory- Brief 
Arabic (N=438) 
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Figure 2. Scree plot for exploratory factor analysis of the Cancer Behavior Inventory- Brief 
Arabic for women with breast cancer (n=168) 
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Figure 3. Scree plot of Functional Assessment of Cancer Therapy-Breast Arabic 
excluding the Additional Concerns (breast cancer) subscale  
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Abstract 
Purpose: The objective was to develop an Arabic version of the Cancer Behavior 
Inventory-Brief (CBI-B).  
Methods: The CBI-B was translated into Arabic using two forward and back 
translations. A translation validity index (TVI) was computed from review by an expert 
panel.  
Results: Both back translations had issues with word choice, grammar, and meaning, 
which were resolved by selecting items from each forward translation. Item TVI was 0.83 
- 1.0, with an overall mean of 0.95. 
Conclusion: The Arabic version of the CBI-B (CBI-BA) has acceptable evidence of 
translation validity. Two rounds of forward and back translation of the CBI-BA were 
needed to ensure semantic equivalence of the CBI-BA with the original instrument. 
Further psychometric testing with cognitive interviewing is recommended.  
Keywords: Arabic, Cancer Behavior Inventory - Brief, translation validity, measurement, 
semantic equivalence  
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Introduction 
Globally, more than 1.6 million new cases of cancer are diagnosed and nearly 
600,000 people die from it every year (Howlader et al., 2014). In the Middle East, cancer 
is the fourth leading cause of death (World Health Organization [WHO], 2010). 
According to One World Nation Online (n.d), Arabic is the official language of 26 
countries distributed in Asia and Africa with a collective population of approximately 
300 million citizens (Salim et al., 2009).   
Self-efficacy is conceptually defined as an individual’s belief in his or her abilities 
to carry out a specific behavior under challenging conditions (Bandura, 1977). Measuring 
self-efficacy for coping (SEC) with cancer is important to understanding cancer 
populations’ attitudes toward their condition. The Cancer Behavior Inventory-Brief 
version (CBI-B) is used to measure SEC (Heitzmann et al., 2011), and translated versions 
of the CBI-B are needed to measure SEC of non-English speaking populations.  
Culture has a complex influence on patient behaviors because it provides different 
sources of information to patients developing SEC with cancer (Bandura, 2002; 
Oettingen, 1995). More than verbatim translation, semantic equivalence needs to be 
considered in translating instruments from one language to another. Semantic 
equivalence means that each item of the original instrument has the same meaning in the 
target culture after translation of the instrument into the language of the target culture 
(Beck, Bernal & Froman, 2003). The WHO (n.d.) advocates four steps in the translation 
process: “forward translation, expert panel back-translation, pretesting and cognitive 
interviewing, and [the] final version” (p. 1). Forward and back translations are necessary 
to obtain instruments of good quality for use in different cultures (Sperber, 2004). The 
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translators must be fluent in English, but their mother tongue needs to be the target 
language. Moreover, translations must seek conceptual equivalence to the words and 
phrases of the original instrument. Expert panel reviews of translations ideally use 
multidisciplinary teams of individuals who are bilingual experts in the field of the 
translated instrument (Ohrbach, Bjorner, Jezewski, John & Lobbezoo, 2009). Such teams 
play a major role in determining the differences between, and alternatives for, the 
translated version as compared with the original. 
 Translational validity assesses the extent to which the translated instrument 
reflects the content of the original instrument (Drost, 2011). Similar to assessment of 
content validity, wherein a content validity index is used to rate the relevance of content 
in the instrument (Lynn, 1986), a translational validity index (TVI) may be used to rate 
the equivalence of the original and translated instruments. TVI is determined according to 
differences and similarities between the translated instrument and the original based on 
expert opinion.  
Guidelines proffered by others for quality of instrument translations (Pan & 
Puente, 2005) address reliability, completeness, accuracy, and cultural appropriateness of 
the translated instrument. Reliable indicates that the translated instrument conveys the 
meaning of the original. Complete indicates that no information in the original is 
supplemented or deleted in the translated instrument. Accurate refers to proper grammar 
and spelling. Culturally appropriate indicates that the concepts of the instrument, and 
how participant responses are elicited, are relevant to the target population. A review 
panel and adjudicators assess the foregoing criteria.  
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In this paper, the authors report the results of the first two steps of the WHO 
process of translating an instrument: forward and back translation and expert panel 
review. The objectives of this study were to (1) forward and back translate the CBI-B into 
Arabic, and (2) assess the TVI of the final forward translated version of the CBI-BA. 
Documentation of each step of the translation process is recommended for tracking 
different versions of the instrument as it proceeds through the various phases of 
development and testing by providing an audit trail of decisions made and their rationale 
(Pan & Puente, 2005). 
Background and Conceptual Framework 
 The translation process recommended by the WHO (n.d.) is shown in Figure 1. 
The original instrument was translated from English to Arabic two times (Forward 
translations 1 and 2).  Then back translations 1 and 2 were compared to obtain a final 
version of the forward translation in Arabic. This “final” version was reviewed by the 
expert panel. 
Cancer Behavior Inventory-Brief (CBI-B) 
The CBI-B is a 14-item, paper and pencil, self-report scale developed to measure 
SEC of cancer patients (Heitzmann et al., 2011). Heitzmann et al. reported Cronbach’s 
alpha of 0.84 to 0.88, indicating adequate evidence of internal consistency reliability. 
Factor analysis (N = 735) demonstrated evidence of construct validity for the CBI-B; the 
hypothesized four subscales were supported by the loading of all items on a 4-factor 
solution, according to theoretical expectations. The CBI-B uses a 9-point Likert-type 
response format (1 = not at all confident, 9 = totally confident). The sum of the item 
scores indicates the level of SEC, with high scores reflecting strong SEC.  
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Methods 
The translation process illustrated in Figure 1 was used to translate the CBI-B to 
the Arabic version (CBI-BA). The original instrument was forward and back translated 
twice, then expert panel review was done to determine semantic equivalence between the 
original and the translated instruments. The purpose of two translations was to produce an 
Arabic version with acceptable semantic equivalence to the CBI-B.  
Translation of the CBI-B to the CBI-BA  
Forward and back translations  
Two individuals bilingual in English and Arabic, with the latter as their native 
language, and who had lived in Arabic cultures were selected to do the translation. First, 
an Arabic-speaking professional translator in Saudi Arabia translated the CBI-B from 
English to Arabic. Then, an Arabic-speaking translator in the United States translated the 
Arabic version of the CBI-B back into English. The authors compared the back-translated 
CBI-BA with the CBI-B and noted several differences in word choice and/or grammar.  
According to Maneesriwongul and Dixon (2004), if the back translation does not 
achieve semantic equivalence, the translation should be replicated. Therefore, a second 
forward translation was done in the United States by an Arabic-speaking translator, with 
a background in medical terminology, and the first author did the back translation.  
Expert panel review 
The panel review represented the opinions of six Arabic-speaking medical and 
linguistic experts regarding equivalence between the translated (CBI-BA) and the original 
(CBI-B) instruments. The expert panel included one oncologist, one general surgeon, two 
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oncology registered nurses, one oncology technician, and one English literature 
specialist. The experts independently completed a translational validity form regarding 
the extent of similarities and differences between the Arabic and English versions for 
each item of the translated instrument. “Similar” and “somewhat similar” options were 
considered acceptable equivalence, and “different” and “somewhat different” responses 
were considered nonequivalent. More than one response of “different” or “somewhat 
different” indicated the need for revision. A TVI was used to quantify the experts’ 
judgment.  
Results 
The authors detected issues with the CBI-BA when comparing the CBI-B and the 
first back translated version. In the instructions, the word “treatment” was back translated 
to “medication,” and the word “behavior” was back translated to “act.” Four instrument 
items had problems with word choice, grammar, and translation. Item 5, “putting things 
out of my mind at times,” was back translated to “freeing my mind from thinking for a 
while;” the back translation had a different meaning. Item 7, “trying to be calm 
throughout treatments and not allowing scary thoughts to upset me,” was back translated 
to “trying to remain calm while in treatment and blocking frightening thoughts,” which is 
not a faithful translation of the phrase. Item 9, “asking physicians questions” was back 
translated to “asking questions to the doctor,” which is grammatically incorrect. The 
word “concerns” in item 11 was back translated into “interests,” which has a different 
meaning.  
When the CBI-B and the second back translation were compared, issues appeared 
with Items 2, 5, 10, and 12. Item 2, “maintaining a positive attitude,” was back translated 
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to “maintaining a positive direction,” which has a different meaning. Item 5, “putting 
things out of my mind at times,” was back translated to “putting off thinking about things 
from time to time;” this is different wording, but conveys the same meaning. Item 10, 
“seeking social support,” was back translated to “looking for social support,” which also 
uses a different word but communicates the same meaning. Item 12, “managing nausea 
and vomiting,” was back translated to “dealing with nausea and vomiting,” which does 
not convey the intended meaning. 
The authors selected the items that were closest to the original instrument from 
either the first or second forward translation (Table 1); the selections were based on the 
back translation of each version.  The bolded items in Table 1 were used for the CBI-BA. 
This version of the forward translation and the original instrument were sent to an expert 
panel for review. Item CVI varied between 0.83 and 1.0, with an overall mean CVI of 
0.95 (Table 2), indicating adequate evidence of translation validity and that the CBI-BA 
achieved semantic equivalence to the CBI-B.  
Discussion 
The CBI-B was translated from English to Arabic using the WHO process of 
translating an instrument, which includes back translation. Back translation of 
instruments is an effective method to validate the meaning of the original instrument 
(Sperber, 2004). Two back translations were compared to obtain more accurate and 
meaningful words and/or phrases that were close to the original instrument’s meaning. 
Bilingual expert review of translated instruments is a method to validate the translated 
instrument (Sperber, 2004). The multiple, bilingual translators had lived in Arabic 
cultures and could draw on their language and cultural backgrounds to assess semantic 
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equivalence.  Improper word choices, grammatical mistakes, and incorrect meanings 
were issues with both back translations. The issues were resolved by author selection of 
some words/phrases from forward translation 1 and some from forward translation 2. The 
TVI indicates that the current version of the CBI-BA has adequate evidence of semantic 
equivalence to the original instrument.  
Arabic language variations in word use can raise issues when translating concepts 
because there are many synonyms in Arabic for English words. This is a potential 
limitation of the present study, as the goal is to produce an instrument that can be used 
broadly with Arabic-speaking populations. The second back translation was done by the 
first author, which could be a source of bias.  
Conclusions and Recommendations 
The CBI-BA has evidence of acceptable translational validity and is semantically 
equivalent to the CBI-B. Further testing with cognitive interviewing is recommended to 
validate interpretation of CBI-BA items by Arabic-speaking cancer patients. 
Psychometric testing is required to assess evidence for validity and reliability of the CBI-
BA. 
 
 
 
 
 
 
 
ARABIC TRANSLATION OF CBI-B                                                                      102                               
  
 
 
References 
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. 
Psychological Review, 84, 191–215. Retrieved from 
http://www.uky.edu/~eushe2/Bandura/Bandura1977PR.pdf 
Bandura, A. (2002). Social cognitive theory in cultural context. Applied Psychology, 
51(2), 269–290. doi: 10.1111/1464-0597.00092. 
Beck, C. T., Bernal, H., & Froman, R. D. (2003). Methods to document semantic 
equivalence of a translated scale. Research in Nursing & Health,26(1), 64-73. 
Drost, E. A. (2011). Validity and reliability in social science research. Education 
Research and Perspectives, 38(1), 105. Retrieved from 
http://www.erpjournal.net/wp-content/uploads/2012/07/ERPV38-1.-Drost-E.-
2011.-Validity-and-Reliability-in-Social-Science-Research.pdf  
Heitzmann, C. A., Merluzzi, T. V., Jean-Pierre, P., Roscoe, J. A., Kirsh, K. L., & 
Passik, S. D. (2011). Assessing self-efficacy for coping with cancer: 
development and psychometric analysis of the brief version of the Cancer 
Behavior Inventory (CBI-B). Psychooncology, 20(3), 302–312. doi: 
10.1002/pon.1735 
Howlader, N., Noone, A. M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S. F., . . . 
Cronin KA (Eds.). (2014). SEER Cancer Statistics Review, 1975–2011. 
Bethesda, MD: National Cancer Institute. Retrieved from 
http://seer.cancer.gov/csr/1975_2011/ 
Lynn, M. R. (1986). Determination and quantification of content validity. Nursing 
Research, 35(6), 382–386. 
Maneesriwongul, W., & Dixon, J. K. (2004). Instrument translation process: a methods 
review. Journal of Advanced Nursing, 48(2), 175-186. doi: 10.1111/j.1365-
2648.2004.03185.x 
Oettingen, G. (1995). Cross-cultural perspectives on self-efficacy. Self-efficacy in 
changing societies, 149-176.  
ARABIC TRANSLATION OF CBI-B                                                                      103                               
  
 
 
Ohrbach, R., Bjorner, J., Jezewski, M. A., John, M. T., & Lobbezoo, F. (2009). 
Guidelines for establishing cultural equivalency of instruments. New York: 
University at Buffalo 
Pan, Y., & de la Puente, M. (2005). Census Bureau Guideline for the Translation of 
Data Collection Instruments and Supporting Materials: Documentation on How 
the Guideline Was Developed. Research Report Series (Survey Methodology 
#2005-06). U. S. Bureau of the Census, Washington, D. C. 
Salim, E. I., Moore, M. A., Al-Lawati, J. A., Al-Sayyad, J., Bazawir, A., Bener, A., . . . 
&Sobue, T. (2009). Cancer epidemiology and control in the Arab world—past, 
present and future. Asian Pacific Journal Cancer Prevention, 10(1), 3–16. 
Sperber, A. D. (2004). Translation and validation of study instruments for cross-cultural 
research. Gastroenterology, 126, Supplement 1(0), S124-S128. doi: 
http://dx.doi.org/10.1053/j.gastro.2003.10.016 
World Health Organization. (n.d.). Process of translation and adaptation of 
instruments. Retrieved from 
http://www.who.int/substance_abuse/research_tools/translation/en/  
World Health organization. Strategies for Cancer Prevention and Control in Eastern 
Mediterranean Region 2009-2013. Retrieved from 
http://applications.emro.who.int/dsaf/EMRPUB_2010_1278.pdf (02/23/2014) 
 
ARABIC TRANSLATION OF CBI-B                                                                      104                               
  
 
 
 
 
 
 
 
Figure 1. The process used to translate the Cancer Behavior Inventory - Brief to the 
Cancer Behavior Inventory – Brief Arabic 
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Table 1  
Back translated versions of the CBI-B with reasons for selection for the CBI-BA 
Original item on the 
CBI-B  
Back translated item 
version 1  
Back translated item 
version 2  
Reason for selection  
1. Maintaining 
independence 
Maintaining 
independence 
Maintain 
independence 
Same as original 
instrument  
2. Maintaining a 
positive attitude 
Maintaining a positive 
attitude 
Maintaining a positive 
direction  
Same as original 
instrument 
3. Maintaining a sense 
of humor 
Maintaining a sense of 
humor  
Maintain a sense of 
humor 
Same as original 
instrument 
4. Expressing feelings 
about cancer 
Expressing my feelings 
about cancer 
Expression of feelings 
about cancer 
Original  
5. Putting things out of 
my mind at times 
Freeing my mind from 
thinking for a while  
Putting off thinking 
about things from 
time to time  
The second meaning is 
easier to understand and 
closer to the original item. 
6. Maintaining 
activities (work, 
home, hobbies, 
social) 
Keeping active (work, 
home, hobbies and 
social activities)  
Maintaining activities 
(work, home, hobbies 
and social activities) 
The second meaning is 
easier to understand and 
closer to the original item. 
7. Trying to be calm 
throughout 
treatments and not 
allowing scary 
thoughts to upset me 
Trying remain calm 
while in treatment and 
blocking frightening 
thoughts  
Trying to be calm 
during treatment and 
avoiding frightening 
ideas that upset me  
The second translation is 
closer to the original item.  
8. Actively 
participating in 
treatment decisions 
Taking an active role in 
treatment decisions  
Participating actively 
in treatment 
decisions  
The second translation is 
easier to understand.  
9. Asking physicians 
questions 
Asking questions of the 
doctor  
Asking questions of 
the physician  
Grammar mistakes appear 
in both translations, and 
the word “physician” is 
more accurate, especially 
within the medical field. 
10. Seeking social 
support 
Seeking social support Looking for social 
support  
Close to the original item  
11. Sharing my worries 
or concerns with 
others 
Sharing worries and 
interests with others  
Sharing my fears and 
concerns with others  
Concerns convey the 
intended meaning of the 
item. 
12. Managing nausea 
and vomiting 
(whether or not I 
have had these 
problems in the 
past) 
Controlling vomiting 
or nausea, whether I 
have suffered from 
these before or not  
Dealing with nausea 
and vomiting (whether 
I have had these before 
or not)  
“Dealing with” 
communicates a different 
meaning. “Managing” and 
“controlling” convey the 
same meaning in Arabic.  
13. Coping with 
physical challenges 
Facing physical 
challenges  
Coping with physical 
challenges  
Same as original item. 
14. Trying to be calm 
while waiting at 
least one hour for 
my appointment 
Trying to maintain calm 
while waiting for the 
appointment for more 
than one hour  
Trying to maintain 
calm while waiting 
for the appointment 
for at least one hour  
First translation is overly 
complicated.  
*Note. The bold items were selected for the CBI-BA. CBI-B, Cancer Behavior Inventory – Brief; CBI-BA, 
Cancer Behavior Inventory – Brief Arabic 
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Table 2  
Expert panel responses to equivalence of the Arabic and English versions of the Cancer Behavior 
Inventory – Brief  
Item  Arabic and English versions are  TVI 
similar somewhat 
similar 
somewhat 
different 
different  
1. Maintaining independence 6 0 0 0 1.00 
2. Maintaining a positive 
attitude  
4 2 0 0 1.00 
3. Maintaining a sense of 
humor  
6 0 0 0 1.00 
4. Expressing feelings about 
cancer  
5 0 1 0 0.83 
5. Putting things out of my 
mind at times 
4 1 0 1 1.00 
6. Maintaining activities 
(work, home, hobbies, 
social)  
6 0 0 0 1.00 
7. Trying to be calm 
throughout treatments and 
not allowing scary 
thoughts to upset me  
5 0 1 0 0.83 
8. Actively participating in 
treatment decisions  
5 1 0 0 0.83 
9. Asking physicians 
questions  
6 0 0 0 1.00 
10. Seeking social support  4 1  1 0.83 
11. Sharing my worries or 
concerns with others  
6 0 0 0 1.00 
12. Managing nausea and 
vomiting (whether or not I 
have had these problems 
in the past)  
5 1 0 0 1.00 
13. Coping with physical 
challenges  
5 1 0 0 1.00 
14. Trying to be calm while 
waiting at least one hour 
for my appointment  
5 1 0 0 1.00 
Mean  TVI*                                    0.95 
*Note. TVI, translation validity index  
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Abstract  
 
Purpose: The study aims were to (a) test reliability of the Arabic versions of the Cancer 
Behavior Inventory – Brief (CBI-BA) among general cancer patients and the Functional 
Assessment of Cancer Therapy - Breast (FACT-BA) in women with breast cancer, and 
(b) assess participant understanding of CBI-BA items.     
Methods: A cross-sectional design was used to assess preliminary evidence for internal 
consistency reliability of the CBI-BA and the FACT-BA in a community-dwelling 
sample of Arabic-speaking persons diagnosed with cancer. Participants were randomly 
selected for cognitive interview.   
Results: Cronbach’s alphas were ≥.76 for the CBI-BA, .91 for the FACT-BA, and .43-
.89 for the FACT-BA subscales. Cognitive interviews revealed several CBI-BA items 
required revision.    
Conclusion: The total CBI-BA and the FACT-BA scales have adequate internal 
consistency reliability estimates.  
Keywords: Arabic, cancer, cognitive interview, quality of life, reliability, self-efficacy 
for coping  
 
 
CBI-BA AND FACT-BA RELIABILITY ESTIMATES                                                110                          
 
 
Introduction  
Cancer is the fourth leading cause of death in Asian and African countries with 
Arabic as the official language (World Health organization [WHO], 2014). Cancer affects 
both physical and psychological aspects of people’s lives (Moradian,  Aledavood, & 
Tabatabaee, 2012; Stein, Syrjala, & Andrykowski, 2008), not only at the time of 
diagnosis and treatment but long afterwards as well (Drake, 2012). Arabic-speaking 
individuals may benefit from the availability of valid and reliable instruments to measure 
self-efficacy for coping (SEC) with cancer and quality of life (QOL) as SEC with cancer 
appears to predict QOL and survival (Yeung, Lu, & Lin, 2014). Figure 1 shows the 
relationship between SEC and QOL in people with cancer. Individual characteristics of 
knowledge, attitude, culture, and social influences determine responses to a cancer 
diagnosis; and coping abilities influence responses both to cancer diagnosis and treatment 
(Lev, 1997). High SEC leads to positive behaviors reflected in high QOL (Heitzmann et 
al., 2011), and low SEC influences coping behaviors in a negative manner, leading to 
poor QOL (Akin, Can, Durna & Aydiner, 2008; Yeung et al.).  
Culture influences patient behaviors because it provides specific sources of 
information that are used to develop SEC (Bandura, 2002). Furthermore, culture shapes 
QOL because it frames how people function within their environment (Skevington, 
2002). Arabic women with breast cancer differ from American and European women: 
Arabic women are diagnosed at a younger age and with a more advanced stage of cancer 
(Chouchane, Boussen, & Sastry, 2013; Sarhan, 2009). In particular, anxiety, fear, 
shyness, and stigma influence attitudes of Arabic women toward breast cancer and 
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coping (Al-Zaben, Sehlo, & Koenig, 2015; Amin, Almulhim & Almeqihwi, 2009; 
Donnelly et al., 2013; Sarhan, 2009).  
Cross-cultural measures are essential for international research (Skevington, 
2002; Sousa & Rojjanasrirat, 2011), and both research and clinical practice with Arabic 
populations would benefit from psychometrically sound instruments in the Arabic 
language. We recently translated the Cancer Behavior Inventory - Brief (CBI-B), a 
measure of SEC, into Arabic (Algamdi & Hanneman, in press). Others translated the 
Functional Assessment of Cancer Therapy - Breast (FACT-B), a measure of QOL, into 
Arabic (available at: http://www.facit.org/FACITOrg/Questionnaires). We did not locate 
published estimates of reliability for these Arabic translations; therefore, the purpose of 
the present study was to estimate reliability of the respective Arabic versions – the CBI-
BA and the FACT-BA. Furthermore, because participant understanding of instrument 
items is essential to validity of the measurement, we used cognitive interviewing (Reeve 
et al., 2011) to assess participant understanding of the meaning of each item of the CBI-
BA and revised items that were not understood in the intended way.  
Methods 
 The study was approved as exempt from review by the University of Texas 
Health Science Center at Houston Committee for the Protection of Human Subjects. 
Verbal consent was obtained for study participation.  A cross-sectional design was used 
to assess preliminary evidence for internal consistency reliability of (a) the CBI-BA in 
cancer patients and (b) the FACT-BA in a subsample of women with breast cancer. The 
assessment included two phases: the original instruments in Arabic were tested (Phase I), 
then revised and tested again with different research participants (Phase II). Participants 
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with any cancer diagnosis completed the CBI-BA, and those with breast cancer also 
completed the FACT-BA.  
A subsample of participants was selected randomly for cognitive interview 
regarding their understanding of CBI-BA items. Before data collection, six numbers from 
1-50 in Phase I and eight numbers from 1-50 in Phase II were selected randomly by 
computer. Participants with study identification codes that matched the randomly selected 
numbers were invited to participate in cognitive interview after they completed the study 
instrument(s). If a preselected participant declined interview, random numbers were 
regenerated based on the remaining numbers of participants to be recruited. The cognitive 
interview participants were asked the following questions about each item on the CBI-
BA: 
a. What did this question mean to you? 
b. Why did you select this answer? 
c. Can I rephrase this question to make it easier to understand? If so, how? 
Participant responses to the questions were recorded manually for later discussion with a 
professional translator and CBI-BA item revision.  
Sample and Setting   
Arabic-speaking adults were recruited from the Greater Houston Metropolitan 
community with the snowball sampling technique (Polit & Beck, 2012) and flyers (with 
contact information) posted at mosques and housing complexes of Arabic- speaking 
residents. Eligibility criteria were age between 18 and 75 years, diagnosed with cancer, 
and able to read and write Arabic. Persons with cognitive or speech problems were 
excluded from study participation. 
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Instruments  
The CBI-B is a 14-item, self-report, norm-referenced instrument developed to 
measure coping self-efficacy of cancer patients (Heitzmann et al., 2011). The CBI-B uses 
a 9-point, Likert-type scale (1 = not at all confident, 9 = totally confident).  The sum of 
item scores indicates the level of SEC, with higher scores reflecting a stronger SEC than 
lower ones (Heitzmann et al.). It takes ≤ 5 minutes to complete the instrument. 
Heitzmann and colleagues reported adequate internal consistency estimates (Cronbach’s 
alphas of .84 - .88) and evidence of construct validity. Factor analysis (N=735) supported 
the hypothesized four subscales of maintaining independence and positive attitude, 
participation in medical care, coping and stress management, and managing affect. 
Maintaining the original scale format, the CBI-B was translated into Arabic (Algamdi & 
Hanneman, in press); this published translation (CBI-BA) was used in Phase I of the 
present study. Demographic data of age, gender, and type of cancer diagnosis were added 
to the CBI-BA to describe the sample.    
Based on participant feedback from cognitive interviewing in Phase I, two 
changes were made to the CBI-BA: the word “independence” in Item 1 was changed to 
“self-reliance” and the word “cancer” was replaced with “disease” throughout the 
questionnaire. The revised CBI-BA was used in Phase II. 
The FACT-B is a 37-item, self-report, norm-referenced instrument developed to 
measure QOL of women with breast cancer (Brady et al., 1997). The FACT-B uses a 5-
point, Likert-type scale, scored from 0 (not at all) to 4 (very much), and it takes about 10 
minutes to complete.  Brady and colleagues reported adequate evidence of internal 
consistency reliability (Cronbach’s alpha = .90) and construct validity.  Factor analysis 
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(N=295) supported the hypothesized five subscales of physical, social/family, emotional, 
and functional well-being, and additional concerns (breast cancer subscale). The Arabic 
version of the FACT-B (FACT-BA) was used in the present study. 
 Phase I data showed missing responses to FACT-BA items related to sexual 
issues: Item 7 of the Social Well-Being subscale (“I am satisfied with my sex life”) and 
Item 4 of the Breast/Additional Concerns subscale (“I feel sexually attractive”). 
Responses to those two items were made optional (Revised FACT-BA) for Phase II 
testing. 
Data Collection  
The principal investigator (first author), an Arabic woman with Arabic as the 
native language and English as second language, collected the data. Upon contact by a 
potential participant, she arranged a meeting to review the study procedures, obtain 
informed consent, and administer the instrument(s) in a private area. The principal 
investigator remained with the participant to answer questions, according to standardized 
script in the study protocol; check the instrument(s) for missing responses upon 
completion; invite participation in cognitive interviewing of pre-selected participants; and 
conduct the interviews. 
Data Analysis 
Missing data was handled by imputation whereby the average individual response 
was used when the corrected item-to-total correlation was ≥ .3 (Donders, van der 
Heijden, Stijnen, & Moons, 2006). We considered optional items in the FACT-BA as 
missing values. Distribution of age and scale scores was assessed with histogram and the 
Kolmogorov-Smirnov normality test. Measures of central tendency and dispersion were 
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computed for the sample demographics and item and total scores for the CBI-BA and 
FACT-BA. Cronbach’s alpha was computed, with α ≥ .70 considered evidence of 
adequate internal consistency (Nunnally & Bernstein, 1994). 
For the cognitive interview data, CBI-BA items with more than three constructive 
comments were targeted for revision. Fewer than three comments, together with 
acceptable explanation of the response choice (interview question b), was considered 
acceptable semantic equivalence (Beck, Bernal, & Froman, 2003) of the CBI-BA with the 
CBI-B.  
Results 
A total of 97 participants completed the CBI-BA, 29 women with breast cancer 
also completed the FACT-BA, and 14 participants completed the cognitive interview. For 
Phase I, conducted between June and August 2014, 50 participants were recruited and 48 
(96%) completed the instrument(s). Of these participants, 17 were women with breast 
cancer, 16 (94.1%) of whom completed the FACT-BA. Six persons participated in 
cognitive interviewing. For Phase II, conducted in September and October 2014, 55 
participants were recruited and 49 (89%) met the eligibility criteria and completed the 
instrument(s); of those, 13 women with breast cancer completed the FACT-BA. Eight 
persons participated in cognitive interviewing. Participant demographics are shown in 
Table 1. Internal consistency reliability estimates are shown in Table 2; the table shows 
data for each testing phase and for the combined sample. Because the sample sizes for the 
FACT-BA were small and the differences between the original and revised versions were 
making responses to 2 of 37 items optional (in contrast to changes in the items per se), we 
tested Cronbach’s alpha with the combined sample to see if larger sample size, and hence 
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greater variability, would impact alpha. For consistency in format of presentation, we 
presented the results in the same way for the CBI-BA in Tables 2 and 3. 
CBI-BA scores were normally distributed with mean (± SD) = 91.5 (±15.4); 
minimum and maximum values were 52 and 121, respectively.  Cronbach’s alpha was .76 
- .77, and mean inter-item correlation was .20. As expected, alpha did not change 
materially when both Phase I and Phase II samples were combined because the sample 
size of each phase was sufficiently large for a stable estimate of internal consistency. 
  Of the women with breast cancer, 14 (87%) and 10 (77%), for item 7 and item 4 
respectively, were reluctant to respond to FACT-BA items of a sexual nature. FACT-BA 
scores were normally distributed, with and without the optional items. Mean values (± 
SD) were 97 (±25) and 93 (±24), with and without the optional items respectively; 
minimum and maximum values ranged from 44 to135 with the optional items and from 
42 to 130 without the optional items. Cronbach’s alpha was .91, and mean inter- item 
correlation was .23. Cronbach’s alpha for the subscales varied from .43 - .89; reliability 
was estimated with exclusion and inclusion of the two sexual items (Table 2).  The 
combined results from Phase I and Phase II testing reflect more stable estimates of 
Cronbach’s alpha with a larger sample size than the separate phases.  
Table 3 shows the results of cognitive interviewing for each phase and the 
combined sample. In Phase I interviews, two of six participants misunderstood the word 
“independent” in item 1 and most disliked the word “cancer” in item 4. In Phase II 
interviews, four of eight participants misinterpreted the meaning of items 5 (“putting 
things out of my mind at times”) and 10 (“seeking social support”). Participants offered 
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comments for rephrasing of items; the comments (and number of participants who 
commented) are listed in the last column of Table 3. 
Discussion 
In this study, we tested preliminary evidence for reliability of the CBI-BA and 
FACT-BA after administration to an Arabic-speaking sample of community-dwelling 
patients in Houston, Texas who had been diagnosed with cancer. We also assessed the 
meaning of CBI-BA items through cognitive interviews. For general cancer patients, the 
internal consistency reliability estimate of the CBI-BA was acceptable and exceeded the a 
priori criterion of α ≥ .70 for a newly developed instrument (Nunnally & Bernstein, 
1994).  Heitzmann et al. (2011) reported higher levels (.84 - .88) of Cronbach’s alpha 
with the original CBI-B. Cognitive interviews suggested some difficulties with 
participant understanding of CBI-BA items 5 and 10; poor understanding in the present 
sample may have affected responses and, thus, reliability of the instrument.  
For women with breast cancer, the internal consistency reliability estimate of the 
FACT-BA (α = .91) was acceptable and exceeded the a priori criterion of α ≥ .70 for a 
newly developed instrument. Making optional two items of a sexual nature did not 
change the reliability estimate of the total scale, but affected subscale reliability 
estimates.  
 The Physical Well-being subscale was not revised but the Cronbach’s alpha 
increased from phase I to phase II, in which response to two items in other subscales 
were optional, and was similar to the Cronbach’s alpha of the original instrument (Brady 
et al., 1997). The Social Well-being subscale produced unstable reliability estimates, 
which may have resulted from low response rate, small sample size, and the smaller 
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number of subscale items (from 8 to 7 with optional response). Nonetheless, inclusion of 
the optional items resulted in adequate internal consistency evidence of the Social Well-
being subscale, with alpha coefficients equivalent to or higher than the original 
instrument testing results (Brady et al.).  The Emotional Well-being and Functional Well-
being subscales performed the same or better in this Arabic sample compared with the 
original instrument Cronbach’s alphas (Brady et al.).  Internal consistency evidence for 
the breast cancer subscale (Special Concerns subscale) improved when response to the 
sexual item was optional and exceeded the ≥ .70 a priori criterion for Cronbach’s alpha 
and the reliability estimate for the original instrument (Brady et al.).  
The FACT-BA subscales had acceptable internal consistency reliability estimates 
when two items that address sexual content were deleted from analysis. Sample size was 
marginally higher when the two items were treated as missing values. Therefore, it seems 
prudent to keep the items optional to be sensitive to the culture of Arabic women with 
breast cancer.  
Cognitive interviewing is a time-honored method to assess semantic equivalence 
of the translated instrument with the original one (Beck, Bernal, & Froman, 2003). Our 
criteria for item revision were three or more constructive comments or wrong 
explanations. As shown in Table 3, comments and understanding varied between Phase I 
and Phase II testing, even though the population and methodology were the same. 
Examining the misunderstanding of CBI-BA items across testing phases shows that one 
or more interviewed participants misunderstood 7 of 14 items, albeit only items 5 and 10 
achieved our a priori threshold for revision. Further refinement of the semantic 
equivalence is indicated. 
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Conclusions, Recommendations, and Implications for Practice 
The CBI-BA has acceptable evidence of internal consistency reliability. Items 5 
and 10 require revision to improve understanding of item meaning. Further cognitive 
interviewing is recommended to increase the semantic equivalence. The FACT-BA and it 
subscales have acceptable evidence of internal consistency reliability when the responses 
to two items of a sexual nature are included in computation of Cronbach’s alpha. If those 
two items are deleted from the FACT-BA, error is unacceptable in the Social Well-being 
subscale.  
Preliminary testing of the CBI-BA and FACT-BA provided adequate evidence of 
internal consistency reliability, making these instruments potentially worthy of clinical 
and research use with Arabic-speaking populations. Continued refinement of the 
semantic equivalence and testing for validity is in progress. 
If further testing of these instruments shows adequate evidence of validity and 
reliability, the CBI-BA, which measures SEC with cancer, and the FACT-BA, which 
measures QOL, can be used with Arabic-speaking women with breast cancer to test the 
relations posited in Figure 1. The CBI-BA would be useful for testing SEC with cancer in 
Arabic-speaking men and women with any type of cancer. 
 
 
 
CBI-BA AND FACT-BA RELIABILITY ESTIMATES                                                120                          
 
 
References 
Akin, S., Can, G., Durna, Z., & Aydiner, A. (2008) The quality of life and self-efficacy of 
Turkish breast cancer patients undergoing chemotherapy. European Journal of 
Oncology Nursing ,12 449–456. doi:10.1016/j.ejon.2008.07.006 
Algamdi, M. M., Hanneman, S. K. (in press). Development of an Arabic translation of 
the Cancer Behavior Inventory-Brief. Journal of Nursing Measurement. 
Al-Zaben, F. N., Sehlo, M. G., & Koenig, H. G. (2015). A cross-sectional study of 
anxiety and marital quality among women with breast cancer at a university 
clinic in western Saudi Arabia. Saudi Medical Journal, 36, 1168–1175. 
Retrieved from http://doi.org/10.15537/smj.2015.10.12254. 
Amin, T. T., Almulhim, A. S., & Almeqihwi, A. (2009). Breast cancer knowledge, risk 
factors and screening among adult Saudi women in a primary health care setting. 
Asian Pacific Journal of Cancer Prevention,10,1-4. Retrieved from 
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No1/133c%20Tafik
%20Amin.pdf 
Bandura, A. (2002). Social cognitive theory in cultural context. Applied Psychology, 51, 
269-290. 
Beck, C. T., Bernal, H., & Froman, R. D. (2003). Methods to document semantic 
equivalence of a translated scale. Research in Nursing & Health, 26, 64-73.  
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., . . . 
Shiomoto, G. (1997). Reliability and validity of the Functional Assessment of 
Cancer Therapy-Breast quality-of-life instrument. Journal of Clinical Oncology, 15, 
974-986.  
CBI-BA AND FACT-BA RELIABILITY ESTIMATES                                                121                          
 
 
Chouchane, L., Boussen, H., & Sastry, K. S. (2013). Breast cancer in Arab populations: 
Molecular characteristics and disease management implications. The Lancet 
Oncology, 14(10), e417-e424. 
Donders, A. R. T., van der Heijden, G. J., Stijnen, T., & Moons, K. G. (2006). Review: A 
gentle introduction to imputation of missing values. Journal of Clinical 
Epidemiology, 59, 1087-1091. 
Donnelly, T. T., Al Khater, A. H., Al-Bader, S. B., Al Kuwari, M. G., Al-Meer, N., 
Malik, M., ... & Fung, T. (2013). Beliefs and attitudes about breast cancer and 
screening practices among Arab women living in Qatar: A cross-sectional 
study. BMC women's health, 13(1), 49.   
Drake, K. (2012). Quality of life for cancer patients: From diagnosis to treatment and 
beyond. Nursing Management, 43(2), 20-25. 
Heitzmann, C. A., Merluzzi, T. V., Jean-Pierre, P., Roscoe, J. A., Kirsh, K. L., & Passik, 
S. D. (2011). Assessing self-efficacy for coping with cancer: Development and 
psychometric analysis of the brief version of the Cancer Behavior Inventory 
(CBI-B). Psychooncology, 20, 302-312. doi: 10.1002/pon.1735 
Lev, E. (1997). Bandura's Theory of Self-Efficacy: Applications to oncology. Scholarly 
Inquiry for Nursing Practice, 11(1), 21-23, 25-37.  
Moradian, S., Aledavood, S. A., & Tabatabaee, A. (2012). Iranian cancer patients and 
their perspectives: A qualitative study. European Journal of Cancer Care, 21, 
377-383. 
Nunnally, J. C., & Bernstein, I. H.  (1994). Psychometric Theory (3rd ed.). New York: 
McGraw-Hill. 
CBI-BA AND FACT-BA RELIABILITY ESTIMATES                                                122                          
 
 
Polit, D. F., & Beck, C. T. (2012). Nursing Research: Generating and Assessing 
Evidence for Nursing Practice. Philadelphia: Wolters Kluwer Health/Lippincott 
Williams & Wilkins. 
 Reeve, B. B., Willis, G., Shariff-Marco, S. N., Breen, N., Williams, D. R., Gee, G. C., ... 
& Levin, K. Y. (2011). Comparing cognitive interviewing and psychometric 
methods to evaluate a racial/ethnic discrimination scale. Field Methods, 23, 397-
419. 
Sarhan, M. M. (2009, November). Breast cancer in the Eastern meditation region: A 
burden with potential. Poster session presented at International Symposium on 
Breast Cancer in the Developing World: Meeting Unforeseen Challenges to 
Women, Health and Equity, Boston, MA.  
Skevington, S. M. (2002). Advancing cross-cultural research on quality of life: 
Observations drawn from the WHOQOL development. Quality of Life 
Research,11(2), 135-144. 
Sousa, V. D., & Rojjanasrirat, W. (2011). Translation, adaptation and validation of 
instruments or scales for use in cross‐cultural health care research: A clear and 
user‐friendly guideline. Journal of Evaluation in Clinical Practice, 17, 268-274. 
Stein, K. D., Syrjala, K. L., & Andrykowski, M. A. (2008). Physical and psychological 
long-term and late effects of cancer. Cancer, 112(S11), 2577-2592. doi: 
10.1002/cncr.23448 
World Health Organization. Strategies for Cancer Prevention and Control in Eastern 
Mediterranean Region 2009-2013. Retrieved from 
http://applications.emro.who.int/dsaf/EMRPUB_2010_1278.pdf (02/23/2014) 
CBI-BA AND FACT-BA RELIABILITY ESTIMATES                                                123                          
 
 
Yeung, N. Y., Lu, Q., & Lin, W. (2014). Specificity may count: Not every aspect of 
coping self-efficacy is beneficial to quality of life among Chinese cancer 
survivors in China. International Journal of Behavioral Medicine, 1-9. doi: 
10.1007/s12529-014-9394-6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CBI-BA AND FACT-BA RELIABILITY ESTIMATES                                                124                          
 
 
 
 
 
 
Figure1. The conceptual framework shows the relation between self-efficacy for coping 
(SEC) and quality of life (QOL) in patients with cancer. 
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Table 1 
Demographic characteristics of the sample  
Phase I 
n=48 
Phase II 
n=49 
Combined 
n=97 
Age (years)  
Mean (±SD) 45.9 (±13.3) 43.3 (±12.2) 44.6 (±12.7) 
Gender  
Male (%) 
Female (%) 
18 (37.5%) 
30 (62.5%) 
23 (46.9%) 
26 (53.1%) 
41 (42.3%) 
56 (57.7%) 
 
Diagnoses 
Breast  16 13 29 
Digestive/gastrointestinal 9 11 19 
Hematologic  7 8 15 
Musculoskeletal  3 4 7 
Respiratory/thoracic  4 2 6 
Gynecologic  3 2 5 
Multiple cancers   3 2 5 
Endocrine/ 
neuroendocrine  
- 3 3 
Genitourinary  2 1 3 
Neurologic  1 1 2 
Otolaryngologic  - 1 1 
Unknown primary  - 1 1 
Total  48 49 97 
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Table 2 
Cronbach’s alpha coefficients for CBI-BA, revised CBI-BA, total FACT-BA and 
subscales and revised total FACT-BA and subscales     
 
 
 
 
 
 
 
Scale Phase I Phase II Combined samples 
CBI-BA Original 
 (n=48) 
Revised 
 (n=49) 
CBI 
(N=97) 
 .76 .78 .77 
FACT-BA Original 
without 
optional 
items  
(n=16) 
Original 
with 
optional 
items 
(n=16) 
Revised  
without 
optional 
items  
(n=12) 
Revised  
with 
optional 
items 
(n=13) 
FACT-BA 
without 
optional 
items   
(N=28) 
FACT-
BA with 
optional 
items 
(N=29) 
Total scale 
.91 .86 .91 .93 .91 .92 
Physical Well-being 
Subscale .78 - .91 - .86 - 
Social  Well-being 
Subscale .71 .71 .43 .85 .68 .80 
Emotional  Well-being 
Subscale .73 - .75 - .74 - 
Functional  Well-being 
Subscale .82 - .89 - .87 - 
Breast Cancer Subscale 
(Special Concerns) .67 .67 .85 .77 .77 .71 
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Table 3  
 
Cognitive interview findings for the Cancer Behavior Inventory – Brief, Arabic version  
 Phase I  Phase II  Combined   
Recommended paraphrasing and comments 
(number of participants) 
CBI-BA 
Items 
Correct 
(n) 
Wrong 
(n) 
Correct 
(n) 
Wrong 
(n) 
Correct 
(n) 
Wrong 
(n) 
1. Maintaining independence  
4 2 8 0 12 2 
Depend on self, maintaining self-dependence, and 
extent to which you can maintain self-reliance (3) 
2. Maintaining a positive attitude  
6 0 7 1 13 1 
Accept the disease and live with it, being positive and 
optimistic toward the illness, and extent to which you 
can maintain positive attitude (2) 
3. Maintaining a sense of humor  
6 0 8 0 14 0 
Humor based on personality, use fun instead of humor, 
extent to which you can maintain sense of humor, and 
humor-like positive attitude (4) 
4. Expressing feelings about cancer  
6 0 7 1 13 1 
Positive or negative feelings, and extent to which you 
can express feelings about the disease (2) 
5. Putting things out of my mind at times 
6 0 4 4 10 4 
“Thing” must refer to the illness or treatment, 
Extent to which you can talk about what is on your 
mind from time to time (3), 
Don’t see difference between items 4 and 5 
6. Maintaining activities (work, home, 
hobbies, social)  6 0 8 0 14 0 
“Social” must refer to social life, Extent to which you 
can maintain activities (work, home, hobbies, social) 
(2)  
7. Trying to be calm throughout 
treatments and not allowing scary 
thoughts to upset me  
6 0 8 0 14 0 
Reconcile yourself with treatment and avoid negative 
thoughts, Extent to which you can be calm throughout 
treatments and not allow scary thoughts to upset me (2) 
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Table 3  
 
Cognitive interview findings for the Cancer Behavior Inventory – Brief, Arabic version (continued) 
 Phase I  Phase II  Combined   
Recommended paraphrasing and comments 
(number of participants) 
CBI-BA 
Item 
Correct 
(n) 
Wrong 
(n) 
Correct 
(n) 
Wrong 
(n) 
Correct 
(n) 
Wrong 
(n) 
8. Actively participating in treatment decisions  
6 0 7 1 13 1 
Make decisions regarding my treatment plan and extent to 
which you can actively participate in treatment decisions (1) 
9. Asking physicians questions  6 0 8 0 14 0 Extent to which you can ask physicians questions (1) 
10. Seeking social support  
6 0 4 4 10 4 
Looking for help from others, Extent to which you can seek 
help (2) 
11. Sharing my worries or concerns with others  
6 0 8 0 14 0 
Extent to which you can share my worries and concerns with 
others (1) 
12. Managing nausea and vomiting (whether or not I 
have had these problems in the past)  6 0 8 0 14 0 
Change manage to prepare for or cope, Extent to  
which you can manage nausea and vomiting (2)   
13. Coping with physical challenges  
6 0 6 2 12 2 
Challenges might be changed to difficulties or problems, 
Overcome the sense of helplessness toward any daily 
activity such as exercise, 
Extent to which you can cope with physical challenges (3) 
14. Trying to be calm while waiting at least one hour 
for my appointment  
6 0 8 0 14 0 
Accept long time waiting for my appointment, 
Extent to which you can be calm while waiting at least one 
hour for my appointment (2) 
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Factor Analysis Results Not Included in the Manuscript. 
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           Table C 1   
            Exploratory factor analysis for 14-item Cancer Behavior Inventory-Brief Arabic 
with orthogonal rotation in general cancer patients (N=438) 
 
Item Number 
Factor 
1 2 3 
2 .692 .256 -.056 
1 .679 .189 -.098 
13 .640 -.026 .105 
6 .639 .139 .037 
7 .585 .172 .064 
3* .518 .358 -.024 
14 .452 -.035 .166 
8* .402 .331 .071 
5 .046 .554 .276 
4 .155 .538 .215 
9* .349 .363 .228 
11 -.027 .323 .623 
10 -.003 .160 .514 
12* .373 .036 .381 
Note. * Cross-loaded item. 
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Table C 2.  
Exploratory factor analysis for 14-item Cancer Behavior Inventory-Brief Arabic 
with oblique rotation in general cancer patients (N=438) 
 
 
 
 
 
 
 
 
 
 
 
 
Note. * Cross-loaded item. 
 
 
 
 
 
 
 
 
 
Item Number Factor 
1 2 3 
13 .714 -.196 .099 
1 .669 .073 -.155 
2 .664 .141 -.125 
6 .653 .004 -.005 
7 .585 .052 .017 
14 .517 -.171 .168 
3* .444 .296 -.109 
12* .426 -.102 .377 
8* .334 .278 -.004 
5 -.109 .590 .170 
4 .010 .555 .109 
9* .279 .304 .153 
11 -.084 .289 .578 
10 -.013 .111 .497 
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Table C 3 
Exploratory factor analysis for 12-item Cancer Behavior Inventory-Brief Arabic  
with orthogonal rotation in general cancer patients (N=438) 
 
Item Number Factor 
1 2 
2 .742 .066 
1 .719 -.014 
6 .646 .080 
7 .596 .143 
3 .588 .153 
13 .581 .048 
8 .453 .215 
9* .406 .395 
12* .318 .296 
11 -.008 .699 
10 -.024 .569 
4* .265 .381 
Note. * Cross-loaded item. 
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Table C 4   
Exploratory factor analysis for 14-item Cancer Behavior Inventory-Brief Arabic with 
oblique rotation in women with breast cancer (n=168) 
 
Item Number Factor 
1 2 3 4 
2 .801 -.023 .114 -.056 
6 .734 -.135 -.159 .208 
3 .679 .149 -.079 .008 
1 .649 -.043 .102 -.063 
13 .548 .002 .120 -.059 
7 .513 .004 .180 -.018 
14 .506 .018 .079 -.111 
12* .361 .256 -.142 .086 
4 .205 .796 -.105 -.053 
5 -.185 .672 .196 -.078 
8 .167 .006 .776 .066 
9* .062 .209 .368 .173 
10 .021 -.172 .097 .733 
11 -.168 .308 .046 .532 
Note. * Cross-loaded item. 
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Table C 5 
Exploratory factor analysis for 14-item Cancer Behavior Inventory-Brief Arabic with 
orthogonal rotation in women with breast cancer (n=168)      
 
Item Number Factor 
1 2 3 
2 .806 .024 .278 
3 .676 .197 .066 
1 .670 -.022 .210 
6 .645 .134 .008 
7 547 .061 .279 
13 .516 .044 .250 
12* .343 .297 .013 
11 -.089 .777 .079 
10 .057 .426 .128 
4* .297 .418 .147 
8 .316 .203 .693 
9* .140 .387 .507 
Note. * Cross-loaded item. 
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Table C 6               
Exploratory factor analysis for 12-item Cancer Behavior Inventory-Brief Arabic with 
oblique rotation in women with breast cancer (n=168)      
 
Item Number Factor 
1 2 3 
2 .790 -.100 .125 
3 .737 .134 -.114 
6 .725 .085 -.171 
1 .664 -.122 .082 
7 .498 -.042 .191 
13 .476 -.051 .165 
12* .385 .274 -.101 
11 -.119 .783 .049 
10 .018 .402 .102 
4* .280 .371 .063 
8 .068 .029 .739 
9 -.048 .272 .543 
Note. * Cross-loaded item. 
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Table C 7.  
 
Exploratory factor analysis for 37-item Functional Assessment of Cancer Therapy-Breast 
Arabic with orthogonal rotation in women with breast cancer (n= 167)  
 
 
Note. *Cross-loaded item; r, reverse-scored. 
 
 
 
 
Item Factor 
1 2 3 4 5 6 7 8 9 10 11 
func2 .812 -.007 .123 .295 .051 -.149 -.041 .028 .217 -.073 -.031 
func1 .748 -.137 .050 .291 .187 -.078 .097 .186 .138 -.014 .045 
phys3r .729 .089 -.236 -.084 .027 .053 .045 -.012 .149 .076 .059 
phys4r .718 .079 .034 -.265 -.036 .086 .119 .200 -.004 .058 -.157 
phys1r .671 .145 -.053 -.031 -.033 .228 .054 -.050 -.075 .283 .327 
phys6r .669 .178 .208 .025 .052 .263 -.018 -.096 -.186 -.018 .284 
phys2r .569 .176 -.027 -.129 .096 .078 .332 -.034 -.122 .252 -.021 
func3* .568 065 .170 .319 .233 .185 .369 -.115 .112 -.280 -.142 
emotion6r .190 .806 .081 .080 .112 .180 .104 -.028 -.035 .170 .078 
concern6r .080 .740 -.017 .037 -.274 -.171 .073 .190 -.012 -.060 -.030 
concern5r -.054 .683 -.138 -.068 .168 -.011 .123 .176 .147 -.328 .051 
concern7r .336 .660 .194 .020 .254 .221 .079 -.037 .270 -.044 -.011 
emotion5r* -.074 .528 .149 .143 .506 .121 .031 .001 -.025 -.019 .060 
concern8r* -.092 .508 .248 .202 .115 -.033 -.044 .447 -.022 -.172 .143 
func4* .185 .447 .113 .182 .366 .124 .054 -.122 -.204 -.196 -.096 
concern4* .024 .344 -.249 .225 .093 .026 .095 -.295 .051 -.029 -.315 
social5 .036 .022 .888 -.089 .066 .045 .000 .029 -.086 .040 .029 
social4* .127 .016 .673 .506 -.082 -.077 .186 .062 -.040 .154 .062 
social6 -.111 .198 .565 .019 -.032 .197 .304 .096 .126 .151 .168 
social2* -.121 .024 .538 .454 -.030 .194 .041 .111 .034 -.043 -.137 
func7* .355 .078 .497 .275 .289 .120 .400 -.349 .082 -.225 -.154 
social3 -.204 .320 .214 .684 .036 .088 .141 -.164 -.055 .070 .039 
social1 .078 .019 -.005 .612 .009 .175 .062 .079 .091 -.042 -.058 
concern9* .214 .003 -.214 .328 .199 .207 -.025 -.018 .119 -.191 .077 
emotion2 .074 .097 -.054 -.011 .768 .057 .028 .037 .059 -.054 .016 
phys7r* .502 -.022 -.067 .031 .525 .092 .211 .348 -.177 .085 .109 
social7* .204 .098 .452 .047 .479 -.224 .081 -.213 .171 .204 .076 
emotion4r .159 .080 .140 .198 -.110 .834 .122 .046 .278 .039 .162 
emotion3r .016 -.005 -.018 .093 .131 .689 .042 -.040 -.054 -.011 -.019 
emotion1r* .339 .293 .251 .179 .085 .512 .000 -.084 .152 .156 -.112 
func5 .210 .180 .196 .142 .014 .103 .913 .067 .041 .114 -.008 
func6 .266 .170 .149 .446 .307 .016 .544 -.220 -.087 -.092 .071 
concern10r .279 .293 .070 -.004 .027 -.045 .005 .624 .185 .065 -.023 
concern3r .094 -.034 -.123 .097 .040 -.071 -.017 .175 .564 .189 .340 
concern2r .034 .053 .032 .019 .006 .104 .013 -.003 .431 -.015 -.050 
concern1r .136 -.134 .136 -.029 -.013 .047 .057 .028 .083 .546 -.032 
phys5r* .491 .241 .168 -.074 .263 .145 .058 .001 .186 -.259 .662 
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Table C 8 
 
Exploratory factor analysis for 37-item Functional Assessment of Cancer Therapy-
Breast Arabic with oblique rotation in women with breast cancer (167)   
 
 
Note. *Cross-loaded item; r, reverse-scored. 
Item Factor 
1 2 3 4 5 6 7 8 9 10 11 
func2 .964 -.034 .056 .218 -.128 -.231 -.192 .120 .148 -.032 .048
phys4r .829 .081 .095 -.346 -.093 .048 .081 .296 -.055 .072 -.138
func1 .821 -.215 -.024 .251 .105 -.121 .005 .263 .069 .035 .075
phys3r .816 .089 -.313 -.110 -.069 -.012 -.009 .007 .119 .093 .092
phys1r .720 .103 -.129 .021 -.147 .125 -.006 -.104 -.120 .258 .278
phys6r .698 .090 .187 -.014 -.146 .141 -.156 -.134 -.277 -.099 .336
phys2r .558 .144 -.089 -.174 .044 -.010 .310 -.015 -.141 .282 -.090
func3 .468 -.077 .038 .133 .036 .108 .252 -.061 .050 -.274 -.020
concern6r .168 .887 -.070 .057 -.418 -.261 .084 .273 -.047 -.146 -.057
emotion6r .111 .827 -.031 .080 .045 .051 .013 .037 -.054 .179 -.017
concern5r -.191 .724 -.212 -.143 .116 -.061 .135 .241 .129 -.401 .142
concern7r .203 .624 .117 -.120 .172 .114 -.055 .073 .256 .003 .044
func4* .100 .389 .042 .099 .295 .035 -.098 -.055 -.260 -.201 -.095
social5 -.037 -.071 1.073 -.247 .019 -.009 -.100 .088 -.113 .050 .087
social4* .123 -.061 .649 .479 -.211 -.150 .108 .112 -.084 .177 .008
social6* -.311 .110 .586 -.069 -.069 .153 .329 .105 .138 .154 .176
social2* -.165 -.057 .549 .419 -.069 .200 -.043 .200 -.003 -.004 -.164
concern4* .014 .385 -.411 .198 .045 -.023 .020 -.244 .072 .034 -.365
func7* .173 -.090 .405 .009 .079 .008 .251 -.317 .053 -.197 -.012
concern9* .171 -.072 -.349 .343 .153 .205 -.094 -.020 .082 -.189 .116
social3 -.292 .274 .026 .740 -.061 .016 .057 -.157 -.071 .090 -.072
social1 .081 -.037 -.154 .677 -.042 .182 .001 .127 .052 -.005 -.121
emotion2 -.147 -.024 -.096 -.093 .954 .057 -.061 .109 .067 .064 .014
phys7r .414 -.147 -.099 .036 .646 .083 .177 .416 -.238 .138 .028
emotion5r -.276 .462 .077 .095 .572 .057 -.079 .077 -.034 .036 .014
social7* .056 .008 .436 -.106 .502 -.323 -.049 -.158 .204 .342 .094
emotion4r .000 -.066 .059 .195 -.176 .845 .091 .023 .256 .038 .186
emotion3r -.120 -.136 -.058 .105 .174 .724 -.009 -.057 -.075 .006 -.054
emotion1r* .283 .212 .198 .127 .045 .460 -.152 .003 .131 .248 -.156
func5 -.036 .068 .035 .015 -.107 .028 1.025 .062 .044 .102 -.026
func6* .070 .028 -.067 .337 .136 -.101 .485 -.247 -.121 -.105 .088
concern10r .332 .334 .116 .022 .110 -.026 .021 .798 .143 .107 -.075
concern8r* -.144 .517 .261 .223 .115 -.057 -.072 .558 -.086 -.225 .130
concern3r .025 -.043 -.215 .140 .093 -.057 .037 .169 .611 .262 .369
concern2r -.033 .040 -.002 -.053 .007 .117 .003 .042 .467 .052 .022
concern1r .155 -.144 .150 .024 .113 .050 .059 .064 .129 .692 -.194
phys5r .312 .106 .109 -.190 .066 .027 -.004 -.092 .126 -.390 .890
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Table C 9           
Exploratory factor analysis for 27-item Functional Assessment of Cancer Therapy-
Breast Arabic with orthogonal rotation in women with breast cancer (n=167)   
 
Item Factor 
1 2 3 4 5 6 
phys6r .707 .064 .365 .162 .016 .003 
phys1r .702 .142 .118 -.030 -.063 -.092 
phys4r .694 .174 .194 .070 -.101 -.037 
phys7r* .650 .133 .055 -.010 .111 .488 
phys3r .617 .095 .072 -.042 .097 -.003 
phys2r .577 .201 .247 -.050 -.108 .215 
phys5r .568 .113 .323 .041 .120 .044 
func7 .096 .792 .184 .316 .065 .053 
func3 .278 .786 .143 .146 .072 .043 
func4 -.016 .675 .147 .041 .057 .157 
func2 .437 .666 -.183 .161 .132 -.118 
func6 .211 .663 .242 .169 .126 .089 
func1* .517 .581 -.123 .112 .126 -.077 
func5* .356 .515 .159 .331 -.011 .020 
emotion4r .307 .035 .654 .018 .216 -.236 
emotion1r .388 .203 .653 .112 .059 -.049 
emotion6r .173 .065 .644 .112 -.068 .111 
emotion5r .033 .106 .562 . 207 -.039 .339 
emotion3r .229 .185 .506 -.018 .204 .074 
social5 .020 .044 .007 .789 .046 .024 
social4 .031 .204 .010 .704 .062 -.078 
social2 -.064 .040 .081 .559 .281 .035 
social7 .067 .267 .032 .502 .096 .136 
social6 .031 .124 .247 .481 .077 -.062 
social1 .103 .153 .162 .209 .700 -.006 
social3 -.061 .124 .002 .219 .646 .098 
emotion2* .008 .344 .132 -.012 .181 .384 
 
     Note. *Cross-loaded item; r, reverse-scored. 
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